Autosomal Recessive Ataxia Beauce Type

Mendelian MONDO:0012549 Pathograph 37 Show in embeddings browser hereditary disease neurodegenerative disease

Autosomal recessive ataxia, Beauce type (autosomal recessive cerebellar ataxia type 1, ARCA1; SCAR8; recessive ataxia of Beauce; ATX-SYNE1) is a SYNE1-related hereditary cerebellar ataxia originally described in French-Canadian families from the Beauce region of Quebec. The classic founder phenotype is a relatively pure, slowly progressive, adult-onset cerebellar syndrome (gait and limb ataxia, cerebellar dysarthria, dysmetria, ocular motor abnormalities) with diffuse cerebellar atrophy on imaging and no peripheral neuropathy, evolving to moderate disability without effect on life expectancy. SYNE1 deficiency, however, spans a broader "cerebellar-plus" spectrum, with some patients showing upper and/or lower motor neuron dysfunction, cognitive/affective involvement, and (at the severe end) childhood-onset multisystem disease or arthrogryposis multiplex congenita. The causal mechanism is biallelic loss-of-function SYNE1 variants affecting nesprin-1, a nuclear-envelope spectrin-repeat protein of the LINC (linker of nucleoskeleton and cytoskeleton) complex, with consequent disruption of nuclear-cytoskeletal coupling in cerebellar neurons.

Ask OpenScientist

Ask a research question about Autosomal Recessive Ataxia Beauce Type. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

1
Inheritance
3
Pathophys.
33
Phenotypes
2
Hypotheses
1
Gaps
37
Pathograph
1
Genes
4
Medical Actions
3
Subtypes
3
Differentials
2
References
1
Deep Research
👪

Inheritance

1
Autosomal recessive inheritance HP:0000007
ARCA1/SYNE1 deficiency is caused by biallelic pathogenic SYNE1 variants and follows autosomal recessive inheritance.
Autosomal recessive inheritance
Show evidence (1 reference)
PMID:20301553 SUPPORT Human Clinical
"SYNE1 deficiency is inherited in an autosomal recessive manner. The parents of an affected individual are obligate heterozygotes"
GeneReviews establishes autosomal recessive inheritance with carrier parents.

Subtypes

3
SYNE1-deficient cerebellar ataxia (ARCA1 / Beauce type)
SYNE1 hgnc:17089 HUGO Gene Nomenclature Committee (hgnc) Relation: this subtype is caused by variation in this gene This subtype is caused by variation in SYNE1 (hgnc:17089). hgnc:17089 is a gene from the HUGO Gene Nomenclature Committee.
The mild end and by far the most commonly recognised presentation: a slowly progressive, relatively pure cerebellar syndrome beginning in adulthood. This is the phenotype originally delineated in the French-Canadian Beauce founder families and the one MONDO:0012549 is named for. Phenotypes curated without a subtype qualifier belong to this presentation or to the SYNE1 deficiency spectrum generally.
Show evidence (1 reference)
PMID:20301553 SUPPORT Human Clinical
"SYNE1-deficient cerebellar ataxia, the most commonly recognized manifestation of SYNE1 deficiency to date, is a slowly progressive disorder typically beginning in adulthood (age range 6-45 years)."
GeneReviews defines the cerebellar-ataxia presentation as the most common manifestation.
SYNE1-deficient childhood-onset multisystem disease
SYNE1 hgnc:17089 HUGO Gene Nomenclature Committee (hgnc) Relation: this subtype is caused by variation in this gene This subtype is caused by variation in SYNE1 (hgnc:17089). hgnc:17089 is a gene from the HUGO Gene Nomenclature Committee.
A less common presentation combining ataxia with upper and lower motor neuron dysfunction, muscle weakness and wasting, and intellectual disability, with onset in childhood rather than adulthood.
Show evidence (1 reference)
PMID:20301553 SUPPORT Human Clinical
"The two less common phenotypes are SYNE1-deficient childhood-onset multisystem disease (ataxia, upper and lower motor neuron dysfunction, muscle weakness and wasting, intellectual disability)"
GeneReviews defines the childhood-onset multisystem presentation and its component features.
SYNE1-deficient arthrogryposis multiplex congenita
SYNE1 hgnc:17089 HUGO Gene Nomenclature Committee (hgnc) Relation: this subtype is caused by variation in this gene This subtype is caused by variation in SYNE1 (hgnc:17089). hgnc:17089 is a gene from the HUGO Gene Nomenclature Committee.
The severe end of the spectrum, presenting prenatally and neonatally with decreased fetal movements, severe hypotonia, and multiple congenital joint contractures including clubfoot. Mechanistically part of SYNE1 deficiency but clinically remote from the adult-onset Beauce ataxia.
Show evidence (1 reference)
PMID:20301553 SUPPORT Human Clinical
"SYNE1-deficient arthrogryposis multiplex congenita (decreased fetal movements and severe neonatal hypotonia associated with multiple congenital joint contractures including clubfoot)"
GeneReviews defines the arthrogryposis presentation at the severe end of the spectrum.

Mechanistic Hypotheses

2
Canonical SYNE1/Nesprin-1 Loss-of-Function LINC Model
canonical_syne1_loss_linc_model CANONICAL
Evidence balance 1 support
The best-supported model is biallelic SYNE1 loss of function producing absent or truncated nesprin-1, impairing the LINC complex that couples the nucleus to the cytoskeleton. Because most disease-associated SYNE1 alleles are truncating, a loss-of-function mechanism is favored, with cerebellar neurons (particularly Purkinje cells) being especially vulnerable, leading to cerebellar degeneration.
Show evidence (1 reference)
PMID:17503513 SUPPORT Human Clinical
"The function of SYNE1 is thus critical in the maintenance of cerebellar structure in humans."
The original ARCA1 study links SYNE1 to maintenance of cerebellar structure, supporting loss-of-function cerebellar degeneration.
Cerebellar Synaptic Nesprin-1 Isoform Model
cerebellar_synaptic_nesprin_isoform_model EMERGING
Evidence balance 3 support
A cerebellum-enriched nesprin-1 isoform lacking the KASH domain localizes to synapses rather than the nuclear envelope, suggesting a synaptic, LINC-complex- independent contribution to cerebellar vulnerability. This extends rather than replaces the canonical nuclear-envelope loss-of-function model and remains to be causally established.
Classified as emerging because the synaptic-isoform mechanism rests on expression, splicing, and subcellular-localization data in mouse cerebellum rather than direct causal demonstration in SCAR8 patients. Note that this model relocates the primary lesion away from the Purkinje nuclear envelope and toward mossy-fibre/granule-cell synaptic compartments; the two models make different predictions about which cerebellar cell population is the proximal target.
Show evidence (3 references)
PMID:25843669 SUPPORT Model Organism
"We also identified a CNS-specific splicing event that leads to the abundant expression of a KASH-LESS variant of Nesprin1 giant (KLNes1g) in the cerebellum."
Identifies the cerebellum-enriched KASH-less nesprin-1 isoform that this hypothesis is built on. Evidence source is MODEL_ORGANISM because the splicing, localization, and immunoprecipitation data are from mouse cerebellum.
PMID:25843669 SUPPORT Model Organism
"KLNes1g displayed a noncanonical localization at glomeruli of cerebellar mossy fibers whereas Nesprin2 exclusively decorated the nuclear envelope of all cerebellar neurons."
Shows the isoform localizes to synaptic rather than nuclear-envelope compartments, which is the specific claim distinguishing this model from the canonical LINC model.
PMID:39519078 SUPPORT Other
"mutations in genes associated with the LINC complex have been implicated in several neurological diseases, including neurodegenerative and psychiatric disorders"
This review links LINC-complex gene mutations to neurological disease, supporting nesprin-1/LINC biology as the mechanistic context for SYNE1 ataxia.
?

Discussions and Knowledge Gaps

1
Which cerebellar cell population is the proximal target of SYNE1 loss — the Purkinje cell nuclear envelope, as the canonical LINC model and this entry's pathograph assume, or the mossy-fibre/granule-cell synaptic compartment where the cerebellum-enriched KASH-less nesprin-1 isoform actually localizes?
OPEN QUESTION UNDER DISCUSSION syne1_proximal_cerebellar_target
This entry asserts Purkinje-cell vulnerability in its pathograph and declares conformance to cerebellar_purkinje_degeneration#Purkinje Neuron Degeneration, which is the mainstream reading of GeneReviews and of Dupre's statement that SYNE1 is critical to the maintenance of cerebellar structure. Neither of those sources actually demonstrates Purkinje neuron loss. The direct localization work points the other way: the abundant cerebellar isoform, KLNes1g, is KASH-less, sits at mossy-fibre glomeruli and granule-cell dendritic membranes rather than the nuclear envelope, and it is Nesprin2 - not Nesprin1 - that decorates the nuclear envelope of cerebellar neurons. If that is the operative lesion, the cell-type annotations and the module conformance on the degeneration node are describing the wrong compartment, and the canonical LINC framing is downstream of, or parallel to, the real mechanism rather than upstream of it.
Proposed experiments
Neuropathological series quantifying Purkinje versus granule cell loss
exp_syne1_purkinje_vs_granule_neuropathology
Assemble a systematic autopsy series of genetically confirmed SYNE1 ataxia and quantify Purkinje versus granule cell loss and mossy-fibre glomerular pathology against age-matched controls. Human neuropathology currently rests on isolated case reports, so the entry's Purkinje-centric cell-type annotation is not presently testable against a series.
Supporting outcome
  • Selective Purkinje neuron loss out of proportion to granule cell loss.
Refuting outcome
  • Granule cell or mossy-fibre pathology predominating with relatively preserved Purkinje populations.
Cell-type-specific Syne1 ablation in mouse
exp_syne1_celltype_specific_ablation
Ablate Syne1 selectively in Purkinje cells versus granule cells in mouse and compare ataxia severity and cerebellar histology, to establish which population is sufficient to produce the phenotype.
Supporting outcome
  • Purkinje-restricted ablation reproducing ataxia.
Refuting outcome
  • Only granule-cell-restricted ablation reproducing ataxia.
KASH-less nesprin-1 isoform expression in human cerebellum
exp_klnes1g_human_cerebellum_localization
Determine whether the KASH-less nesprin-1 isoform is expressed and similarly localized in human cerebellum. The existing splicing and immunogold localization data are from mouse, so the translational validity of the synaptic model to human disease is untested.
Supporting outcome
  • Detection of the KASH-less isoform at human mossy-fibre glomeruli.
Refuting outcome
  • Absence of the isoform, or exclusively nuclear-envelope localization, in human cerebellum.
Recorded during the 2026-08 publication-readiness review. The conformance and the Purkinje cell_types annotations are deliberately retained as the mainstream model rather than removed, but they should not be read as evidence-backed claims about the proximal cellular target. PMID:36525394 (an autopsied SYNE1-ataxia patient) is listed under references as a bibliographic pointer only and is deliberately not cited as evidence anywhere in this entry: PubMed carries no abstract for that letter, so no snippet can be verified against a cached source. Mine it for evidence if full text ever reaches the cache.

Pathophysiology

3
SYNE1/Nesprin-1 Loss of Function
ARCA1 is caused by biallelic SYNE1 variants, most commonly truncating loss-of- function alleles, that reduce or abolish nesprin-1. This establishes the primary molecular lesion. SYNE1 is among the largest human genes, and the spectrum of pathogenic variants includes nonsense, frameshift, splice, missense, and even large intragenic deletions detectable only by CNV-sensitive methods.
SYNE1 hgnc:17089 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves decreased SYNE1 (hgnc:17089). hgnc:17089 is a gene from the HUGO Gene Nomenclature Committee. ↓ DECREASED
SYNE1 hgnc:17089 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves SYNE1 (hgnc:17089). hgnc:17089 is a gene from the HUGO Gene Nomenclature Committee.
Show evidence (2 references)
PMID:17503513 SUPPORT Human Clinical
"We identified a cluster of French-Canadian families with a new recessive ataxia of relatively pure cerebellar type caused by mutations in SYNE1."
Establishes SYNE1 as the causal gene for ARCA1.
PMID:38136976 SUPPORT Human Clinical
"compound heterozygous for a known nonsense variant (c.13258C>T, p.(Arg4420Ter)), and a large intragenic deletion that was predicted to result in a loss of function"
Demonstrates loss-of-function SYNE1 alleles, including a structural deletion, as a cause of ARCA1.
Disrupted Nuclear-Cytoskeletal LINC Coupling
Nesprin-1 participates in the LINC complex spanning the nuclear envelope (SUN-KASH bridging), physically connecting the cytoskeleton to nuclear components and mediating nuclear positioning, cell migration, and mechanotransduction. Loss of nesprin-1 disrupts this coupling. The LINC complex is essential to nervous-system development, and LINC-gene mutations are implicated in neurodegenerative disease.
Cerebellar Purkinje cell CL:0000121 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves Cerebellar Purkinje cell, annotated with Purkinje cell (CL:0000121). CL:0000121 is a cell type from the Cell Ontology. Cerebellar granule cell CL:0001031 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves Cerebellar granule cell (CL:0001031). CL:0001031 is a cell type from the Cell Ontology.
Cytoskeleton organization GO:0007010 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal Cytoskeleton organization (GO:0007010). GO:0007010 is a biological process from the Gene Ontology. ⚠ ABNORMAL Nuclear migration / positioning GO:0007097 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal Nuclear migration / positioning, annotated with nuclear migration (GO:0007097). GO:0007097 is a biological process from the Gene Ontology. ⚠ ABNORMAL
Nuclear envelope GO:0005635 Gene Ontology (GO) Relation: this pathophysiological event involves this cellular component This pathophysiological event involves Nuclear envelope (GO:0005635). GO:0005635 is a cellular component from the Gene Ontology. Nuclear inner membrane GO:0005637 Gene Ontology (GO) Relation: this pathophysiological event involves this cellular component This pathophysiological event involves Nuclear inner membrane (GO:0005637). GO:0005637 is a cellular component from the Gene Ontology.
Show evidence (1 reference)
PMID:39519078 SUPPORT Other
"The linker of nucleoskeleton and cytoskeleton (LINC) complex, which spans the nuclear envelope, physically connects nuclear components to the cytoskeleton and plays a pivotal role in various cellular processes, including nuclear positioning, cell migration, and chromosomal configuration."
Describes the LINC-complex function disrupted by nesprin-1/SYNE1 loss.
Cerebellar Neurodegeneration and Atrophy
Cerebellar neuronal vulnerability, supported by the strong cerebellar expression of SYNE1, produces diffuse cerebellar atrophy without cortical, brainstem, or white-matter involvement in the classic founder phenotype, and underlies the progressive cerebellar ataxia, dysarthria, and dysmetria.
Cerebellar Purkinje cell CL:0000121 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves Cerebellar Purkinje cell, annotated with Purkinje cell (CL:0000121). CL:0000121 is a cell type from the Cell Ontology.
Cerebellum UBERON:0002037 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in Cerebellum (UBERON:0002037). UBERON:0002037 is an anatomical location from the Uberon multi-species anatomy ontology. Cerebellar cortex UBERON:0002129 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in Cerebellar cortex (UBERON:0002129). UBERON:0002129 is an anatomical location from the Uberon multi-species anatomy ontology.
Show evidence (1 reference)
PMID:17503513 SUPPORT Human Clinical
"slow progression and moderate disability, significant dysarthria, mild oculomotor abnormalities, occasional brisk reflexes in the lower extremities, normal nerve conduction studies, and diffuse cerebellar atrophy on imaging"
Documents diffuse cerebellar atrophy as the structural correlate of the cerebellar syndrome.

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for Autosomal Recessive Ataxia Beauce Type Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.

Phenotypes

33
Digestive 1
Dysphagia HP:0002015 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Dysphagia (HP:0002015). HP:0002015 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:20301553 SUPPORT Human Clinical
"dysarthria, dysphagia, cognition, and psychiatric manifestations"
GeneReviews lists dysphagia among the manifestations to be assessed at surveillance visits, implying it occurs in the disorder. This is an indirect assertion; no cited source reports its frequency.
Eye 2
Nystagmus HP:0000639 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Nystagmus (HP:0000639). HP:0000639 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:33526008 SUPPORT Human Clinical
"only the occurrence of gaze-evoked nystagmus, slowing of saccades, broken up smooth pursuits, strabismus and square-wave jerks were reported"
Review of published SYNE1 ataxia patients documents gaze-evoked nystagmus among the reported oculomotor findings.
Strabismus HP:0000486 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Strabismus (HP:0000486). HP:0000486 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:33526008 SUPPORT Human Clinical
"only the occurrence of gaze-evoked nystagmus, slowing of saccades, broken up smooth pursuits, strabismus and square-wave jerks were reported"
A review of previously published SYNE1 ataxia patients lists strabismus among the reported ocular findings. Summary of prior literature.
Limbs 2
Pes cavus HP:0001761 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Pes cavus (HP:0001761). HP:0001761 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:33526008 SUPPORT Human Clinical
"non-neurological abnormalities, including scoliosis, pes cavus or respiratory dysfunction with severe manifestation"
Describes the non-Canadian SYNE1 ataxia cohort, in which most patients had extracerebellar signs including pes cavus.
Talipes equinovarus HP:0001762 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Clubfoot, annotated with Talipes equinovarus (HP:0001762). HP:0001762 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:20301553 SUPPORT Human Clinical
"multiple congenital joint contractures including clubfoot"
GeneReviews names clubfoot among the congenital contractures of the arthrogryposis phenotype.
Musculoskeletal 5
Spasticity HP:0001257 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Spasticity (HP:0001257). HP:0001257 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:20301553 SUPPORT Human Clinical
"many also have upper motor neuron dysfunction (spasticity, hyperreflexia, Babinski sign)"
GeneReviews names spasticity as a component of the upper motor neuron arm. No frequency band is asserted: the source quantifies the upper motor neuron arm as a whole ("many"), not each component sign.
Skeletal muscle atrophy HP:0003202 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Amyotrophy, annotated with Skeletal muscle atrophy (HP:0003202). HP:0003202 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:20301553 SUPPORT Human Clinical
"lower motor neuron dysfunction (amyotrophy, reduced reflexes, fasciculations)"
GeneReviews names amyotrophy as a component of the lower motor neuron arm. No frequency band is asserted for the individual sign.
Scoliosis HP:0002650 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Scoliosis (HP:0002650). HP:0002650 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:33526008 SUPPORT Human Clinical
"non-neurological abnormalities, including scoliosis, pes cavus or respiratory dysfunction with severe manifestation"
Describes the non-Canadian SYNE1 ataxia cohort, in which most patients had extracerebellar signs including scoliosis.
Muscle weakness HP:0001324 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Muscle weakness and wasting, annotated with Muscle weakness (HP:0001324). HP:0001324 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:20301553 SUPPORT Human Clinical
"SYNE1-deficient childhood-onset multisystem disease (ataxia, upper and lower motor neuron dysfunction, muscle weakness and wasting, intellectual disability)"
GeneReviews scopes muscle weakness and wasting to the childhood-onset multisystem phenotype.
Neonatal hypotonia HP:0001319 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Severe neonatal hypotonia, annotated with Neonatal hypotonia (HP:0001319), qualified as severity severe. HP:0001319 is a phenotype from the Human Phenotype Ontology.
Severity: SEVERE
Show evidence (1 reference)
PMID:20301553 SUPPORT Human Clinical
"decreased fetal movements and severe neonatal hypotonia associated with multiple congenital joint contractures including clubfoot"
GeneReviews scopes severe neonatal hypotonia to the arthrogryposis multiplex congenita phenotype.
Nervous System 8
Cerebellar ataxia HP:0001251 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Cerebellar ataxia, annotated with Ataxia (HP:0001251), qualified as course progressive. HP:0001251 is a phenotype from the Human Phenotype Ontology.
Course: PROGRESSIVE
Show evidence (1 reference)
PMID:17503513 SUPPORT Human Clinical
"ARCA-1 is a cerebellar syndrome characterized by recessive transmission, middle-age onset (mean, 31.60; range, 17-46 years), slow progression and moderate disability"
Establishes progressive cerebellar ataxia as the core syndrome.
Gait ataxia HP:0002066 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Gait ataxia (HP:0002066). HP:0002066 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:33526008 SUPPORT Human Clinical
"SYNE1 ataxia is an autosomal recessive hereditary condition, the main characteristic features of which are gait and limb ataxia and cerebellar dysarthria."
Confirms gait ataxia as a core characteristic feature.
Dysarthria VERY_FREQUENT HP:0001260 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Cerebellar dysarthria, annotated with Dysarthria (HP:0001260). HP:0001260 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:17503513 SUPPORT Human Clinical
"ARCA-1 is a cerebellar syndrome characterized by recessive transmission, middle-age onset (mean, 31.60; range, 17-46 years), slow progression and moderate disability, significant dysarthria"
Dupre 2007 defines the syndrome as "characterized by ... significant dysarthria". No cited source reports a dysarthria numerator/denominator, so the VERY_FREQUENT band rests on the qualitative mapping in docs/frequency-evidence-guidelines.md, under which a feature named as characterizing the syndrome maps to VERY_FREQUENT (80-99%). Downgrade or remove the band if a quantitative cohort figure becomes available.
Cerebellar atrophy HP:0001272 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Cerebellar atrophy (HP:0001272). HP:0001272 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:17503513 SUPPORT Human Clinical
"normal nerve conduction studies, and diffuse cerebellar atrophy on imaging"
Documents diffuse cerebellar atrophy on imaging.
Cognitive impairment HP:0100543 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Cognitive impairment (HP:0100543). HP:0100543 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:20301553 SUPPORT Human Clinical
"Most individuals develop features of the cerebellar cognitive and affective syndrome (i.e., significant deficits in attention, executive functioning, verbal working memory, and visuospatial/visuoconstructional skills)."
GeneReviews documents the cerebellar cognitive and affective syndrome in most patients.
Hyperreflexia HP:0001347 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Hyperreflexia (HP:0001347). HP:0001347 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:20301553 SUPPORT Human Clinical
"many also have upper motor neuron dysfunction (spasticity, hyperreflexia, Babinski sign)"
GeneReviews names hyperreflexia as a component of the upper motor neuron arm. No frequency band is asserted for the individual sign.
Fasciculations HP:0002380 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Fasciculations (HP:0002380). HP:0002380 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:20301553 SUPPORT Human Clinical
"lower motor neuron dysfunction (amyotrophy, reduced reflexes, fasciculations)"
GeneReviews names fasciculations as a component of the lower motor neuron arm. No frequency band is asserted for the individual sign.
Intellectual disability HP:0001249 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Intellectual disability (HP:0001249). HP:0001249 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:20301553 SUPPORT Human Clinical
"SYNE1-deficient childhood-onset multisystem disease (ataxia, upper and lower motor neuron dysfunction, muscle weakness and wasting, intellectual disability)"
GeneReviews scopes intellectual disability to the childhood-onset multisystem phenotype, which is why this entry carries a subtype qualifier rather than being asserted of the disease as a whole.
Other 15
Limb ataxia HP:0002070 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Limb ataxia (HP:0002070). HP:0002070 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:33526008 SUPPORT Human Clinical
"the main characteristic features of which are gait and limb ataxia and cerebellar dysarthria"
Confirms limb ataxia as a characteristic feature.
Dysmetria HP:0001310 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Dysmetria (HP:0001310). HP:0001310 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:20301553 SUPPORT Human Clinical
"some individuals have a pure cerebellar syndrome (i.e., cerebellar ataxia, dysarthria, dysmetria, abnormalities in ocular saccades and smooth pursuit)"
GeneReviews lists dysmetria as part of the pure cerebellar syndrome.
Abnormal ocular smooth pursuit Impaired smooth pursuit HP:0007772 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Impaired smooth pursuit (HP:0007772). HP:0007772 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:20301553 SUPPORT Human Clinical
"abnormalities in ocular saccades and smooth pursuit"
GeneReviews documents abnormal ocular saccades and smooth pursuit.
Slow saccades Slow saccadic eye movements HP:0000514 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Slow saccadic eye movements (HP:0000514). HP:0000514 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:33526008 SUPPORT Human Clinical
"The eye tracking assessment revealed hypometric saccades in the longer amplitude (18.4°) saccadic paradigm in all SYNE1 patients, whereas 2 out of 3 SYNE1 subjects performed slow saccades as well."
Eye-tracking study documents slow and hypometric saccades in SYNE1 ataxia patients.
Upper motor neuron dysfunction FREQUENT HP:0002493 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Upper motor neuron dysfunction (HP:0002493). HP:0002493 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:20301553 SUPPORT Human Clinical
"many also have upper motor neuron dysfunction (spasticity, hyperreflexia, Babinski sign) and/or lower motor neuron dysfunction (amyotrophy, reduced reflexes, fasciculations)"
GeneReviews reports that "many" SYNE1-deficient individuals have upper motor neuron dysfunction. Per the qualitative mapping in docs/frequency-evidence-guidelines.md this maps to FREQUENT (30-79%); no cited source gives a numerator/denominator for this arm.
Lower motor neuron involvement (cerebellar-plus) Abnormal lower motor neuron morphology HP:0002366 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Lower motor neuron dysfunction, annotated with Abnormal lower motor neuron morphology (HP:0002366). HP:0002366 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:32889669 SUPPORT Human Clinical
"four patients exhibited non-cerebellar phenotypes, including motor neuron symptoms, cognitive impairment, or mental retardation"
The Chinese cohort documents motor neuron involvement as part of the cerebellar-plus phenotype.
Short attention span HP:0000736 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Deficits in attention, annotated with Short attention span (HP:0000736). HP:0000736 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:20301553 SUPPORT Human Clinical
"significant deficits in attention, executive functioning, verbal working memory, and visuospatial/visuoconstructional skills"
GeneReviews names attention as one of the specific domains impaired in the cerebellar cognitive and affective syndrome. Curated separately from the broader Cognitive impairment entry so the specific HPO term is available.
Lower limb hyperreflexia OCCASIONAL HP:0002395 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Brisk lower extremity reflexes, annotated with Lower limb hyperreflexia (HP:0002395). HP:0002395 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:17503513 SUPPORT Human Clinical
"occasional brisk reflexes in the lower extremities"
Dupre 2007 reports brisk lower-extremity reflexes in the founder cohort. The author term "occasional" maps to OCCASIONAL (5-29%) under the qualitative mapping in docs/frequency-evidence-guidelines.md.
Babinski sign HP:0003487 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Babinski sign (HP:0003487). HP:0003487 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:20301553 SUPPORT Human Clinical
"many also have upper motor neuron dysfunction (spasticity, hyperreflexia, Babinski sign)"
GeneReviews names the Babinski sign as a component of the upper motor neuron arm. No frequency band is asserted for the individual sign.
Reduced tendon reflexes HP:0001315 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Reduced tendon reflexes (HP:0001315). HP:0001315 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:20301553 SUPPORT Human Clinical
"lower motor neuron dysfunction (amyotrophy, reduced reflexes, fasciculations)"
GeneReviews names reduced reflexes as a component of the lower motor neuron arm. No frequency band is asserted for the individual sign.
Square-wave jerks HP:0025402 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Square-wave jerks (HP:0025402). HP:0025402 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:33526008 SUPPORT Human Clinical
"only the occurrence of gaze-evoked nystagmus, slowing of saccades, broken up smooth pursuits, strabismus and square-wave jerks were reported"
A review of 168 previously published SYNE1 ataxia patients lists square-wave jerks among the reported oculomotor findings. The sentence is a summary of prior literature, not a new observation in this cohort.
Jerky ocular pursuit movements HP:0008003 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Broken up smooth pursuit, annotated with Jerky ocular pursuit movements (HP:0008003). HP:0008003 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:33526008 SUPPORT Human Clinical
"only the occurrence of gaze-evoked nystagmus, slowing of saccades, broken up smooth pursuits, strabismus and square-wave jerks were reported"
Adds the specific HPO term for broken-up smooth pursuit alongside the broader Abnormal ocular smooth pursuit entry. Summary of prior literature.
Respiratory dysfunction Abnormality of the respiratory system HP:0002086 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Respiratory dysfunction, annotated with Abnormality of the respiratory system (HP:0002086). HP:0002086 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:33526008 SUPPORT Human Clinical
"non-neurological abnormalities, including scoliosis, pes cavus or respiratory dysfunction with severe manifestation"
Reports respiratory dysfunction as a severe-end extracerebellar manifestation. The HPO term is deliberately broad because the source does not specify the respiratory abnormality.
Decreased fetal movement HP:0001558 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Decreased fetal movement (HP:0001558). HP:0001558 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:20301553 SUPPORT Human Clinical
"SYNE1-deficient arthrogryposis multiplex congenita (decreased fetal movements and severe neonatal hypotonia associated with multiple congenital joint contractures including clubfoot)"
GeneReviews scopes decreased fetal movements to the arthrogryposis multiplex congenita phenotype at the severe end of the spectrum.
Arthrogryposis multiplex congenita HP:0002804 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Arthrogryposis multiplex congenita (HP:0002804). HP:0002804 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:20301553 SUPPORT Human Clinical
"SYNE1 deficiency comprises a phenotypic spectrum that ranges from autosomal recessive cerebellar ataxia at the mild end to arthrogryposis multiplex congenita (AMC) at the severe end."
GeneReviews places arthrogryposis multiplex congenita at the severe end of the SYNE1 deficiency spectrum, anchoring the AMC subtype.
🧬

Genetic Associations

1
Biallelic SYNE1 pathogenic variants
Gene: SYNE1 hgnc:17089 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is SYNE1 (hgnc:17089). hgnc:17089 is a gene from the HUGO Gene Nomenclature Committee.
Autosomal recessive inheritance
Show evidence (2 references)
PMID:20301553 SUPPORT Human Clinical
"The diagnosis of SYNE1 deficiency is established in a proband with suggestive findings and biallelic SYNE1 pathogenic variants identified by molecular genetic testing."
GeneReviews defines the molecular diagnostic basis as biallelic SYNE1 variants.
PMID:32889669 SUPPORT Human Clinical
"We identified eight truncating variants and two missense variants spreading throughout the SYNE1 gene from six unrelated families"
Documents the predominance of truncating SYNE1 variants distributed across the gene.
💊

Medical Actions

4
Supportive and Rehabilitative Care
Action: supportive careNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is supportive care (NCIT:C15747). NCIT:C15747 is a clinical intervention from the NCI Thesaurus. Ontology label: Supportive Care NCIT:C15747
There is no specific or disease-modifying treatment for SYNE1 deficiency. Management is supportive, aiming to maximize function and reduce complications through a multidisciplinary team (neurology, physical/occupational/speech therapy, physiatry, orthopedics, nutrition).
Show evidence (1 reference)
PMID:20301553 SUPPORT Human Clinical
"There is no specific treatment for SYNE1 deficiency. The goals of treatment are to maximize function and reduce complications."
GeneReviews states management is supportive with no specific therapy.
Physical Therapy
Action: Physical TherapyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Physical Therapy (NCIT:C15302). NCIT:C15302 is a clinical intervention from the NCI Thesaurus. NCIT:C15302
Rehabilitation to maintain mobility and address ataxia, spasticity, and weakness.
Show evidence (1 reference)
PMID:20301553 SUPPORT Human Clinical
"managed by a multidisciplinary team of relevant specialists including neurologists, occupational therapists, physical therapists, physiatrists, orthopedists, nutritionists, speech therapists, respiratory therapists, and psychologists"
GeneReviews recommends physical therapy within multidisciplinary management.
Speech Therapy
Action: speech therapyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is speech therapy, annotated with Speech Language Therapy (NCIT:C159273). NCIT:C159273 is a clinical intervention from the NCI Thesaurus. Ontology label: Speech Language Therapy NCIT:C159273
Speech therapy for cerebellar dysarthria and, when present, dysphagia.
Show evidence (1 reference)
PMID:20301553 SUPPORT Human Clinical
"neurologists, occupational therapists, physical therapists, physiatrists, orthopedists, nutritionists, speech therapists, respiratory therapists, and psychologists"
GeneReviews includes speech therapy within multidisciplinary management.
Genetic Counseling
Action: Genetic CounselingNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Genetic Counseling (NCIT:C15240). NCIT:C15240 is a clinical intervention from the NCI Thesaurus. NCIT:C15240
Genetic counseling is indicated given autosomal recessive inheritance; carrier testing, prenatal diagnosis, and preimplantation genetic testing are available once familial variants are known. Relevant in founder populations.
Show evidence (1 reference)
PMID:20301553 SUPPORT Human Clinical
"carrier testing for at-risk relatives, prenatal diagnosis for a pregnancy at increased risk, and preimplantation genetic testing are possible"
GeneReviews supports genetic counseling and reproductive testing options.
🔬

Diagnosis

2
Brain MRI
Brain MRI demonstrating diffuse cerebellar atrophy supports the diagnosis; normal nerve conduction studies help distinguish ARCA1 from ataxias with prominent peripheral neuropathy.
Show evidence (1 reference)
PMID:17503513 SUPPORT Human Clinical
"normal nerve conduction studies, and diffuse cerebellar atrophy on imaging"
Imaging shows diffuse cerebellar atrophy with normal nerve conduction.
Molecular genetic testing (NGS with CNV analysis)
Next-generation sequencing (gene panel, exome, or genome) detects most SYNE1 variants, but CNV-sensitive methods (e.g., array-CGH) are needed to detect large intragenic deletions that standard sequencing pipelines may miss. Diagnostic workup for adult-onset hereditary ataxia combines STR-expansion testing with sequencing.
Show evidence (2 references)
PMID:38136976 SUPPORT Human Clinical
"even rare copy number variations should be considered in patients with a phenotype suggestive of SYNE1 deficiency"
Highlights the need for CNV-sensitive testing in suspected SYNE1 deficiency.
PMID:38760634 SUPPORT Other
"Testing methods include targeted evaluation of STR expansions (e.g. SCAs, Friedreich ataxia, fragile X-associated tremor/ataxia syndrome, dentatorubral-pallidoluysian atrophy), next generation sequencing for conventional variants, which may include targeted gene panels, whole exome, or whole..."
Describes the contemporary diagnostic approach for adult-onset hereditary ataxia.
📈

Progression

2
Adult-onset cerebellar syndrome
Age: Adolescence to mid-adulthood (range ~6-45 years; mean onset ~31.6 years in founder cohort)
Classic Beauce phenotype begins with gait and limb ataxia in early-to-mid adulthood, with dysarthria following. Non-founder cohorts can show earlier (childhood/young-adult) onset.
Show evidence (1 reference)
PMID:20301553 SUPPORT Human Clinical
"SYNE1-deficient cerebellar ataxia, the most commonly recognized manifestation of SYNE1 deficiency to date, is a slowly progressive disorder typically beginning in adulthood (age range 6-45 years)."
GeneReviews documents typical adult onset across a wide age range.
Slowly progressive course
Duration: Slowly progressive over years to decades
The founder phenotype progresses slowly to moderate disability with no effect on life expectancy; cerebellar-plus forms can carry additional morbidity from motor neuron and multisystem involvement.
Show evidence (1 reference)
PMID:17503513 SUPPORT Human Clinical
"recessive transmission, middle-age onset (mean, 31.60; range, 17-46 years), slow progression and moderate disability"
Documents slow progression to moderate disability.
📊

Prevalence

1
Eastern Quebec adults
Point Prevalence 2.67 per 100,000 1–9 per 100,000
In an Eastern Quebec cross-sectional study, ARCA1 (AR cerebellar ataxia type 1) was the most prevalent hereditary ataxia identified, at a minimum prevalence of 2.67/100,000 [95% CI 2.65-2.7], within an overall adult hereditary ataxia prevalence of 6.47/100,000. This is a founder-population figure and a *minimum* (genetically confirmed cases only); it should not be read as a worldwide prevalence for this disorder, and no worldwide estimate is currently curated.
Show evidence (1 reference)
PMID:33397523 SUPPORT Human Clinical
"AR cerebellar ataxia type 1 (2.67/100 000) and AD spastic paraplegia SPG4 (1.18/100 000) were the most prevalent disorders identified."
Provides a population-based minimum prevalence estimate for ARCA1.
🔀

Differential Diagnoses

3

Conditions with similar clinical presentations that must be differentiated from Autosomal Recessive Ataxia Beauce Type:

Overlapping Features The most important differential in the population where ARCA1 was defined: a second recessive ataxia with a Quebec founder effect, present in the same Eastern Quebec ataxia clinics. Both are recessive, both are cerebellar, and both are enriched in the same ancestry, so ancestry alone does not discriminate them.
Distinguishing Features
  • Caused by biallelic SACS variants (sacsin), not SYNE1.
  • Prominent spasticity and peripheral neuropathy, whereas ARCA1 has normal nerve conduction studies and is relatively pure cerebellar.
  • Roughly six-fold rarer than ARCA1 in the same Eastern Quebec population (0.43 vs 2.67 per 100,000).
Show evidence (1 reference)
PMID:33397523 SUPPORT Human Clinical
"Pathogenic mutations in SACS were found in seven non-related patients"
Establishes that SACS-related ARSACS co-occurs with ARCA1 in the same Eastern Quebec cohort, making it the co-located differential.
Overlapping Features The commonest recessive ataxia overall and the comparator against which SYNE1 oculomotor findings have been benchmarked.
Distinguishing Features
  • Caused by a GAA repeat expansion in FXN, detected by repeat-expansion testing rather than sequencing.
  • Sensory axonal neuropathy with absent reflexes; ARCA1 has normal nerve conduction studies.
  • Cardiomyopathy and diabetes are part of Friedreich ataxia and are not features of the ARCA1 founder phenotype.
Show evidence (1 reference)
PMID:33526008 SUPPORT Human Clinical
"compare them to the same parameters of Friedreich ataxia (FA) patients and healthy subjects"
Friedreich ataxia is used as the explicit clinical comparator group in the SYNE1 oculomotor study, reflecting its role as the primary differential.
Primary mitochondrial disease
Overlapping Features SYNE1 deficiency can present with secondary mitochondrial findings and be misclassified as a primary mitochondrial disorder, a diagnostic trap worth recording explicitly because it redirects the whole testing strategy.
Distinguishing Features
  • COX-negative fibers and mtDNA deletions can be present in SYNE1 deficiency as secondary findings.
  • Resolution requires pangenomic (exome plus CNV-sensitive) testing rather than mitochondrial-targeted testing.
Show evidence (1 reference)
PMID:38136976 SUPPORT Human Clinical
"The proband presented with the association of cerebellar ataxia, COX-negative fibers on muscle histology, and mtDNA deletions."
Documents a SYNE1-deficient proband whose muscle and mtDNA findings pointed toward a primary mitochondrial disorder before exome sequencing plus array-CGH identified biallelic SYNE1 variants.
{ }

Source YAML

click to show
name: Autosomal Recessive Ataxia Beauce Type
creation_date: "2026-06-04T12:00:00Z"
category: Mendelian
description: >-
  Autosomal recessive ataxia, Beauce type (autosomal recessive cerebellar ataxia
  type 1, ARCA1; SCAR8; recessive ataxia of Beauce; ATX-SYNE1) is a SYNE1-related
  hereditary cerebellar ataxia originally described in French-Canadian families
  from the Beauce region of Quebec. The classic founder phenotype is a relatively
  pure, slowly progressive, adult-onset cerebellar syndrome (gait and limb ataxia,
  cerebellar dysarthria, dysmetria, ocular motor abnormalities) with diffuse
  cerebellar atrophy on imaging and no peripheral neuropathy, evolving to moderate
  disability without effect on life expectancy. SYNE1 deficiency, however, spans a
  broader "cerebellar-plus" spectrum, with some patients showing upper and/or lower
  motor neuron dysfunction, cognitive/affective involvement, and (at the severe end)
  childhood-onset multisystem disease or arthrogryposis multiplex congenita. The
  causal mechanism is biallelic loss-of-function SYNE1 variants affecting
  nesprin-1, a nuclear-envelope spectrin-repeat protein of the LINC (linker of
  nucleoskeleton and cytoskeleton) complex, with consequent disruption of
  nuclear-cytoskeletal coupling in cerebellar neurons.
parents:
- hereditary disease
- neurodegenerative disease
synonyms:
- autosomal recessive cerebellar ataxia type 1
- ARCA1
- SCAR8
- recessive ataxia of Beauce
- SYNE1-related autosomal recessive cerebellar ataxia
- ATX-SYNE1
disease_term:
  preferred_term: autosomal recessive ataxia, Beauce type
  term:
    id: MONDO:0012549
    label: autosomal recessive ataxia, Beauce type
references:
- reference: PMID:20301553
  title: "SYNE1 Deficiency."
  tags:
  - GeneReviews
- reference: PMID:36525394
  title: "SYNE1-ataxia: clinicopathologic features of an autopsied patient with novel compound heterozygous mutations."
inheritance:
- name: Autosomal recessive inheritance
  description: >-
    ARCA1/SYNE1 deficiency is caused by biallelic pathogenic SYNE1 variants and
    follows autosomal recessive inheritance.
  inheritance_term:
    preferred_term: Autosomal recessive inheritance
    term:
      id: HP:0000007
      label: Autosomal recessive inheritance
  evidence:
  - reference: PMID:20301553
    reference_title: "SYNE1 Deficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "SYNE1 deficiency is inherited in an autosomal recessive manner. The parents of an affected individual are obligate heterozygotes"
    explanation: GeneReviews establishes autosomal recessive inheritance with carrier parents.
has_subtypes:
- name: ARCA1
  display_name: SYNE1-deficient cerebellar ataxia (ARCA1 / Beauce type)
  description: >-
    The mild end and by far the most commonly recognised presentation: a slowly
    progressive, relatively pure cerebellar syndrome beginning in adulthood.
    This is the phenotype originally delineated in the French-Canadian Beauce
    founder families and the one MONDO:0012549 is named for. Phenotypes curated
    without a subtype qualifier belong to this presentation or to the SYNE1
    deficiency spectrum generally.
  genes:
  - preferred_term: SYNE1
    term:
      id: hgnc:17089
      label: SYNE1
  evidence:
  - reference: PMID:20301553
    reference_title: "SYNE1 Deficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "SYNE1-deficient cerebellar ataxia, the most commonly recognized manifestation of SYNE1 deficiency to date, is a slowly progressive disorder typically beginning in adulthood (age range 6-45 years)."
    explanation: GeneReviews defines the cerebellar-ataxia presentation as the most common manifestation.
- name: Childhood-onset multisystem
  display_name: SYNE1-deficient childhood-onset multisystem disease
  description: >-
    A less common presentation combining ataxia with upper and lower motor
    neuron dysfunction, muscle weakness and wasting, and intellectual
    disability, with onset in childhood rather than adulthood.
  genes:
  - preferred_term: SYNE1
    term:
      id: hgnc:17089
      label: SYNE1
  evidence:
  - reference: PMID:20301553
    reference_title: "SYNE1 Deficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The two less common phenotypes are SYNE1-deficient childhood-onset multisystem disease (ataxia, upper and lower motor neuron dysfunction, muscle weakness and wasting, intellectual disability)"
    explanation: GeneReviews defines the childhood-onset multisystem presentation and its component features.
- name: AMC
  display_name: SYNE1-deficient arthrogryposis multiplex congenita
  description: >-
    The severe end of the spectrum, presenting prenatally and neonatally with
    decreased fetal movements, severe hypotonia, and multiple congenital joint
    contractures including clubfoot. Mechanistically part of SYNE1 deficiency
    but clinically remote from the adult-onset Beauce ataxia.
  genes:
  - preferred_term: SYNE1
    term:
      id: hgnc:17089
      label: SYNE1
  evidence:
  - reference: PMID:20301553
    reference_title: "SYNE1 Deficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "SYNE1-deficient arthrogryposis multiplex congenita (decreased fetal movements and severe neonatal hypotonia associated with multiple congenital joint contractures including clubfoot)"
    explanation: GeneReviews defines the arthrogryposis presentation at the severe end of the spectrum.
mechanistic_hypotheses:
- hypothesis_group_id: canonical_syne1_loss_linc_model
  hypothesis_label: Canonical SYNE1/Nesprin-1 Loss-of-Function LINC Model
  status: CANONICAL
  description: >-
    The best-supported model is biallelic SYNE1 loss of function producing absent
    or truncated nesprin-1, impairing the LINC complex that couples the nucleus to
    the cytoskeleton. Because most disease-associated SYNE1 alleles are truncating,
    a loss-of-function mechanism is favored, with cerebellar neurons (particularly
    Purkinje cells) being especially vulnerable, leading to cerebellar degeneration.
  evidence:
  - reference: PMID:17503513
    reference_title: "Clinical and genetic study of autosomal recessive cerebellar ataxia type 1."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The function of SYNE1 is thus critical in the maintenance of cerebellar structure in humans."
    explanation: The original ARCA1 study links SYNE1 to maintenance of cerebellar structure, supporting loss-of-function cerebellar degeneration.
- hypothesis_group_id: cerebellar_synaptic_nesprin_isoform_model
  hypothesis_label: Cerebellar Synaptic Nesprin-1 Isoform Model
  status: EMERGING
  description: >-
    A cerebellum-enriched nesprin-1 isoform lacking the KASH domain localizes to
    synapses rather than the nuclear envelope, suggesting a synaptic, LINC-complex-
    independent contribution to cerebellar vulnerability. This extends rather than
    replaces the canonical nuclear-envelope loss-of-function model and remains to
    be causally established.
  notes: >-
    Classified as emerging because the synaptic-isoform mechanism rests on
    expression, splicing, and subcellular-localization data in mouse cerebellum
    rather than direct causal demonstration in SCAR8 patients. Note that this
    model relocates the primary lesion away from the Purkinje nuclear envelope
    and toward mossy-fibre/granule-cell synaptic compartments; the two models
    make different predictions about which cerebellar cell population is the
    proximal target.
  evidence:
  - reference: PMID:25843669
    reference_title: "A variant of Nesprin1 giant devoid of KASH domain underlies the molecular etiology of autosomal recessive cerebellar ataxia type I."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "We also identified a CNS-specific splicing event that leads to the abundant expression of a KASH-LESS variant of Nesprin1 giant (KLNes1g) in the cerebellum."
    explanation: >-
      Identifies the cerebellum-enriched KASH-less nesprin-1 isoform that this
      hypothesis is built on. Evidence source is MODEL_ORGANISM because the
      splicing, localization, and immunoprecipitation data are from mouse
      cerebellum.
  - reference: PMID:25843669
    reference_title: "A variant of Nesprin1 giant devoid of KASH domain underlies the molecular etiology of autosomal recessive cerebellar ataxia type I."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "KLNes1g displayed a noncanonical localization at glomeruli of cerebellar mossy fibers whereas Nesprin2 exclusively decorated the nuclear envelope of all cerebellar neurons."
    explanation: >-
      Shows the isoform localizes to synaptic rather than nuclear-envelope
      compartments, which is the specific claim distinguishing this model from
      the canonical LINC model.
  - reference: PMID:39519078
    reference_title: "Diverse Roles of the LINC Complex in Cellular Function and Disease in the Nervous System."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "mutations in genes associated with the LINC complex have been implicated in several neurological diseases, including neurodegenerative and psychiatric disorders"
    explanation: This review links LINC-complex gene mutations to neurological disease, supporting nesprin-1/LINC biology as the mechanistic context for SYNE1 ataxia.
pathophysiology:
- name: SYNE1/Nesprin-1 Loss of Function
  biological_scale: MOLECULAR
  description: >-
    ARCA1 is caused by biallelic SYNE1 variants, most commonly truncating loss-of-
    function alleles, that reduce or abolish nesprin-1. This establishes the primary
    molecular lesion. SYNE1 is among the largest human genes, and the spectrum of
    pathogenic variants includes nonsense, frameshift, splice, missense, and even
    large intragenic deletions detectable only by CNV-sensitive methods.
  gene:
    preferred_term: SYNE1
    description: Nesprin-1, a nuclear-envelope spectrin-repeat protein of the LINC complex.
    modifier: DECREASED
    term:
      id: hgnc:17089
      label: SYNE1
  genes:
  - preferred_term: SYNE1
    term:
      id: hgnc:17089
      label: SYNE1
  evidence:
  - reference: PMID:17503513
    reference_title: "Clinical and genetic study of autosomal recessive cerebellar ataxia type 1."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We identified a cluster of French-Canadian families with a new recessive ataxia of relatively pure cerebellar type caused by mutations in SYNE1."
    explanation: Establishes SYNE1 as the causal gene for ARCA1.
  - reference: PMID:38136976
    reference_title: "A Case Report of SYNE1 Deficiency-Mimicking Mitochondrial Disease and the Value of Pangenomic Investigations."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "compound heterozygous for a known nonsense variant (c.13258C>T, p.(Arg4420Ter)), and a large intragenic deletion that was predicted to result in a loss of function"
    explanation: Demonstrates loss-of-function SYNE1 alleles, including a structural deletion, as a cause of ARCA1.
  downstream:
  - target: Disrupted Nuclear-Cytoskeletal LINC Coupling
    description: >-
      Reduced or absent nesprin-1 impairs assembly and function of the LINC complex
      at the nuclear envelope.
    evidence:
    - reference: PMID:39519078
      reference_title: "Diverse Roles of the LINC Complex in Cellular Function and Disease in the Nervous System."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "The linker of nucleoskeleton and cytoskeleton (LINC) complex, which spans the nuclear envelope, physically connects nuclear components to the cytoskeleton"
      explanation: Nesprin-1 is a LINC-complex component, so its loss disrupts LINC assembly at the nuclear envelope.
  - target: Intellectual disability
    description: >-
      Intellectual disability in the childhood-onset multisystem presentation.
      Wired from the primary genetic lesion rather than from cerebellar
      degeneration because that presentation is not the cerebellar syndrome this
      pathograph otherwise models.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:20301553
      reference_title: "SYNE1 Deficiency."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "SYNE1-deficient childhood-onset multisystem disease (ataxia, upper and lower motor neuron dysfunction, muscle weakness and wasting, intellectual disability)"
      explanation: GeneReviews attributes intellectual disability to SYNE1 deficiency in the childhood-onset multisystem presentation.
  - target: Muscle weakness
    description: Muscle weakness and wasting in the childhood-onset multisystem presentation.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:20301553
      reference_title: "SYNE1 Deficiency."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "SYNE1-deficient childhood-onset multisystem disease (ataxia, upper and lower motor neuron dysfunction, muscle weakness and wasting, intellectual disability)"
      explanation: GeneReviews attributes muscle weakness and wasting to SYNE1 deficiency in the childhood-onset multisystem presentation.
  - target: Decreased fetal movement
    description: >-
      Decreased fetal movements in the arthrogryposis presentation. The
      intermediates between nesprin-1 loss and reduced fetal movement are not
      established.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:20301553
      reference_title: "SYNE1 Deficiency."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "SYNE1-deficient arthrogryposis multiplex congenita (decreased fetal movements and severe neonatal hypotonia associated with multiple congenital joint contractures including clubfoot)"
      explanation: GeneReviews attributes decreased fetal movements to SYNE1 deficiency at the severe end of the spectrum.
  - target: Neonatal hypotonia
    description: Severe neonatal hypotonia in the arthrogryposis presentation.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:20301553
      reference_title: "SYNE1 Deficiency."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "decreased fetal movements and severe neonatal hypotonia associated with multiple congenital joint contractures including clubfoot"
      explanation: GeneReviews attributes severe neonatal hypotonia to SYNE1 deficiency at the severe end of the spectrum.
  - target: Arthrogryposis multiplex congenita
    description: >-
      Multiple congenital joint contractures at the severe end of the SYNE1
      deficiency spectrum.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:20301553
      reference_title: "SYNE1 Deficiency."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "SYNE1 deficiency comprises a phenotypic spectrum that ranges from autosomal recessive cerebellar ataxia at the mild end to arthrogryposis multiplex congenita (AMC) at the severe end."
      explanation: GeneReviews places arthrogryposis multiplex congenita within the SYNE1 deficiency spectrum.
  - target: Talipes equinovarus
    description: Clubfoot among the congenital contractures of the arthrogryposis presentation.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:20301553
      reference_title: "SYNE1 Deficiency."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "multiple congenital joint contractures including clubfoot"
      explanation: GeneReviews names clubfoot among the contractures attributable to SYNE1 deficiency.
  - target: Scoliosis
    description: >-
      Scoliosis as a non-neurological feature of the extracerebellar SYNE1
      phenotype. Attributed to the primary lesion because no cerebellar
      mechanism accounts for it.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:33526008
      reference_title: "Eye-tracking-aided characterization of saccades and antisaccades in SYNE1 ataxia patients: a pilot study."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "non-neurological abnormalities, including scoliosis, pes cavus or respiratory dysfunction with severe manifestation"
      explanation: Reports scoliosis among non-neurological features of SYNE1 ataxia outside the founder population.
  - target: Pes cavus
    description: Pes cavus as a non-neurological feature of the extracerebellar SYNE1 phenotype.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:33526008
      reference_title: "Eye-tracking-aided characterization of saccades and antisaccades in SYNE1 ataxia patients: a pilot study."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "non-neurological abnormalities, including scoliosis, pes cavus or respiratory dysfunction with severe manifestation"
      explanation: Reports pes cavus among non-neurological features of SYNE1 ataxia outside the founder population.
  - target: Respiratory dysfunction
    description: Respiratory dysfunction in severely affected non-founder patients.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:33526008
      reference_title: "Eye-tracking-aided characterization of saccades and antisaccades in SYNE1 ataxia patients: a pilot study."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "non-neurological abnormalities, including scoliosis, pes cavus or respiratory dysfunction with severe manifestation"
      explanation: Reports respiratory dysfunction among severe non-neurological manifestations of SYNE1 ataxia.
  - target: Strabismus
    description: >-
      Strabismus is reported in SYNE1 ataxia but is not a cerebellar sign, so it
      is attributed to the primary lesion rather than routed through cerebellar
      degeneration.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:33526008
      reference_title: "Eye-tracking-aided characterization of saccades and antisaccades in SYNE1 ataxia patients: a pilot study."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "only the occurrence of gaze-evoked nystagmus, slowing of saccades, broken up smooth pursuits, strabismus and square-wave jerks were reported"
      explanation: Strabismus appears among the ocular findings reported across published SYNE1 ataxia patients.
- name: Disrupted Nuclear-Cytoskeletal LINC Coupling
  biological_scale: CELLULAR
  conforms_to: "cerebellar_purkinje_degeneration#Cerebellar Neuron Insult"
  description: >-
    Nesprin-1 participates in the LINC complex spanning the nuclear envelope
    (SUN-KASH bridging), physically connecting the cytoskeleton to nuclear
    components and mediating nuclear positioning, cell migration, and
    mechanotransduction. Loss of nesprin-1 disrupts this coupling. The LINC complex
    is essential to nervous-system development, and LINC-gene mutations are
    implicated in neurodegenerative disease.
  cell_types:
  - preferred_term: Cerebellar Purkinje cell
    term:
      id: CL:0000121
      label: Purkinje cell
  - preferred_term: Cerebellar granule cell
    term:
      id: CL:0001031
      label: cerebellar granule cell
  biological_processes:
  - preferred_term: Cytoskeleton organization
    term:
      id: GO:0007010
      label: cytoskeleton organization
    modifier: ABNORMAL
  - preferred_term: Nuclear migration / positioning
    term:
      id: GO:0007097
      label: nuclear migration
    modifier: ABNORMAL
  cellular_components:
  - preferred_term: Nuclear envelope
    term:
      id: GO:0005635
      label: nuclear envelope
  - preferred_term: Nuclear inner membrane
    term:
      id: GO:0005637
      label: nuclear inner membrane
  evidence:
  - reference: PMID:39519078
    reference_title: "Diverse Roles of the LINC Complex in Cellular Function and Disease in the Nervous System."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "The linker of nucleoskeleton and cytoskeleton (LINC) complex, which spans the nuclear envelope, physically connects nuclear components to the cytoskeleton and plays a pivotal role in various cellular processes, including nuclear positioning, cell migration, and chromosomal configuration."
    explanation: Describes the LINC-complex function disrupted by nesprin-1/SYNE1 loss.
  downstream:
  - target: Cerebellar Neurodegeneration and Atrophy
    description: >-
      Disrupted nuclear-cytoskeletal coupling in cerebellar neurons leads to
      cerebellar degeneration manifesting as diffuse cerebellar atrophy.
    evidence:
    - reference: PMID:17503513
      reference_title: "Clinical and genetic study of autosomal recessive cerebellar ataxia type 1."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "The function of SYNE1 is thus critical in the maintenance of cerebellar structure in humans."
      explanation: Loss of SYNE1/nesprin-1 function compromises cerebellar structural maintenance, driving cerebellar degeneration and atrophy.
  - target: Upper motor neuron dysfunction
    description: >
      The broader SYNE1 deficiency spectrum includes upper motor neuron signs
      beyond the pure cerebellar phenotype.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:20301553
      reference_title: "SYNE1 Deficiency."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "many also have upper motor neuron dysfunction (spasticity, hyperreflexia, Babinski sign) and/or lower motor neuron dysfunction (amyotrophy, reduced reflexes, fasciculations)"
      explanation: >
        GeneReviews documents upper motor neuron dysfunction in the broader
        SYNE1 deficiency spectrum.
  - target: Lower motor neuron involvement (cerebellar-plus)
    description: >
      Cerebellar-plus SYNE1 deficiency can include lower motor neuron
      involvement outside the classic pure cerebellar presentation.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:32889669
      reference_title: "Autosomal Recessive Cerebellar Ataxia Type 1: Phenotypic and Genetic Correlation in a Cohort of Chinese Patients with SYNE1 Variants."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "four patients exhibited non-cerebellar phenotypes, including motor neuron symptoms, cognitive impairment, or mental retardation"
      explanation: >
        The Chinese SYNE1 cohort documents motor-neuron symptoms as
        non-cerebellar cerebellar-plus phenotypes.
  - target: Spasticity
    description: Spasticity as a component sign of the upper motor neuron arm.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:20301553
      reference_title: "SYNE1 Deficiency."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "many also have upper motor neuron dysfunction (spasticity, hyperreflexia, Babinski sign)"
      explanation: GeneReviews names spasticity as a component of the upper motor neuron arm of SYNE1 deficiency.
  - target: Hyperreflexia
    description: Hyperreflexia as a component sign of the upper motor neuron arm.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:20301553
      reference_title: "SYNE1 Deficiency."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "many also have upper motor neuron dysfunction (spasticity, hyperreflexia, Babinski sign)"
      explanation: GeneReviews names hyperreflexia as a component of the upper motor neuron arm of SYNE1 deficiency.
  - target: Lower limb hyperreflexia
    description: >-
      Brisk lower-extremity reflexes, the upper motor neuron sign actually
      observed in the otherwise pure-cerebellar Beauce founder cohort.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:17503513
      reference_title: "Clinical and genetic study of autosomal recessive cerebellar ataxia type 1."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "occasional brisk reflexes in the lower extremities"
      explanation: Dupre 2007 reports brisk lower-extremity reflexes in the founder cohort.
  - target: Babinski sign
    description: Extensor plantar response as a component sign of the upper motor neuron arm.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:20301553
      reference_title: "SYNE1 Deficiency."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "many also have upper motor neuron dysfunction (spasticity, hyperreflexia, Babinski sign)"
      explanation: GeneReviews names the Babinski sign as a component of the upper motor neuron arm of SYNE1 deficiency.
  - target: Skeletal muscle atrophy
    description: Amyotrophy as a component sign of the lower motor neuron arm.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:20301553
      reference_title: "SYNE1 Deficiency."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "lower motor neuron dysfunction (amyotrophy, reduced reflexes, fasciculations)"
      explanation: GeneReviews names amyotrophy as a component of the lower motor neuron arm of SYNE1 deficiency.
  - target: Reduced tendon reflexes
    description: Reduced deep tendon reflexes as a component sign of the lower motor neuron arm.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:20301553
      reference_title: "SYNE1 Deficiency."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "lower motor neuron dysfunction (amyotrophy, reduced reflexes, fasciculations)"
      explanation: GeneReviews names reduced reflexes as a component of the lower motor neuron arm of SYNE1 deficiency.
  - target: Fasciculations
    description: Fasciculations as a component sign of the lower motor neuron arm.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:20301553
      reference_title: "SYNE1 Deficiency."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "lower motor neuron dysfunction (amyotrophy, reduced reflexes, fasciculations)"
      explanation: GeneReviews names fasciculations as a component of the lower motor neuron arm of SYNE1 deficiency.
- name: Cerebellar Neurodegeneration and Atrophy
  biological_scale: TISSUE
  conforms_to: "cerebellar_purkinje_degeneration#Purkinje Neuron Degeneration"
  description: >-
    Cerebellar neuronal vulnerability, supported by the strong cerebellar
    expression of SYNE1, produces diffuse cerebellar atrophy without cortical,
    brainstem, or white-matter involvement in the classic founder phenotype, and
    underlies the progressive cerebellar ataxia, dysarthria, and dysmetria.
  cell_types:
  - preferred_term: Cerebellar Purkinje cell
    term:
      id: CL:0000121
      label: Purkinje cell
  locations:
  - preferred_term: Cerebellum
    term:
      id: UBERON:0002037
      label: cerebellum
  - preferred_term: Cerebellar cortex
    term:
      id: UBERON:0002129
      label: cerebellar cortex
  evidence:
  - reference: PMID:17503513
    reference_title: "Clinical and genetic study of autosomal recessive cerebellar ataxia type 1."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "slow progression and moderate disability, significant dysarthria, mild oculomotor abnormalities, occasional brisk reflexes in the lower extremities, normal nerve conduction studies, and diffuse cerebellar atrophy on imaging"
    explanation: Documents diffuse cerebellar atrophy as the structural correlate of the cerebellar syndrome.
  downstream:
  - target: Cerebellar atrophy
    description: Diffuse cerebellar atrophy is the imaging correlate of the cerebellar neurodegenerative process.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:17503513
      reference_title: "Clinical and genetic study of autosomal recessive cerebellar ataxia type 1."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "normal nerve conduction studies, and diffuse cerebellar atrophy on imaging"
      explanation: Documents diffuse cerebellar atrophy on imaging in ARCA1.
  - target: Cerebellar ataxia
    description: Cerebellar degeneration produces the progressive cerebellar ataxia syndrome.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:17503513
      reference_title: "Clinical and genetic study of autosomal recessive cerebellar ataxia type 1."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "ARCA-1 is a cerebellar syndrome characterized by recessive transmission, middle-age onset (mean, 31.60; range, 17-46 years), slow progression and moderate disability"
      explanation: Establishes the progressive cerebellar syndrome caused by SYNE1 deficiency.
  - target: Gait ataxia
    description: Cerebellar degeneration manifests clinically as gait ataxia.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:33526008
      reference_title: "Eye-tracking-aided characterization of saccades and antisaccades in SYNE1 ataxia patients: a pilot study."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "SYNE1 ataxia is an autosomal recessive hereditary condition, the main characteristic features of which are gait and limb ataxia and cerebellar dysarthria."
      explanation: Lists gait ataxia as a main characteristic feature of SYNE1 ataxia.
  - target: Limb ataxia
    description: Cerebellar degeneration impairs appendicular coordination, producing limb ataxia.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:33526008
      reference_title: "Eye-tracking-aided characterization of saccades and antisaccades in SYNE1 ataxia patients: a pilot study."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "the main characteristic features of which are gait and limb ataxia and cerebellar dysarthria"
      explanation: Lists limb ataxia as a characteristic feature of SYNE1 ataxia.
  - target: Dysarthria
    description: Cerebellar degeneration causes the dysarthria component of the syndrome.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:17503513
      reference_title: "Clinical and genetic study of autosomal recessive cerebellar ataxia type 1."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "slow progression and moderate disability, significant dysarthria"
      explanation: Documents dysarthria in the slowly progressive ARCA1 syndrome.
  - target: Dysmetria
    description: Cerebellar degeneration causes dysmetria as part of the pure cerebellar syndrome.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:20301553
      reference_title: "SYNE1 Deficiency."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "some individuals have a pure cerebellar syndrome (i.e., cerebellar ataxia, dysarthria, dysmetria, abnormalities in ocular saccades and smooth pursuit)"
      explanation: GeneReviews lists dysmetria as a component of the pure cerebellar syndrome.
  - target: Abnormal ocular smooth pursuit
    description: Cerebellar degeneration affects ocular motor control, including smooth pursuit.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:20301553
      reference_title: "SYNE1 Deficiency."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "abnormalities in ocular saccades and smooth pursuit"
      explanation: Documents ocular saccade and smooth-pursuit abnormalities in SYNE1 deficiency.
  - target: Slow saccades
    description: Cerebellar ocular motor involvement includes slow saccadic eye movements.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:33526008
      reference_title: "Eye-tracking-aided characterization of saccades and antisaccades in SYNE1 ataxia patients: a pilot study."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "The eye tracking assessment revealed hypometric saccades in the longer amplitude (18.4°) saccadic paradigm in all SYNE1 patients, whereas 2 out of 3 SYNE1 subjects performed slow saccades as well."
      explanation: Eye-tracking documents slow saccades in SYNE1 ataxia.
  - target: Nystagmus
    description: Cerebellar ocular motor involvement includes gaze-evoked nystagmus.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:33526008
      reference_title: "Eye-tracking-aided characterization of saccades and antisaccades in SYNE1 ataxia patients: a pilot study."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "only the occurrence of gaze-evoked nystagmus, slowing of saccades, broken up smooth pursuits, strabismus and square-wave jerks were reported"
      explanation: Review of SYNE1 ataxia oculomotor findings includes gaze-evoked nystagmus.
  - target: Cognitive impairment
    description: Cerebellar involvement can extend to cerebellar cognitive and affective syndrome.
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - cerebellar cognitive and affective syndrome
    evidence:
    - reference: PMID:20301553
      reference_title: "SYNE1 Deficiency."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Most individuals develop features of the cerebellar cognitive and affective syndrome (i.e., significant deficits in attention, executive functioning, verbal working memory, and visuospatial/visuoconstructional skills)."
      explanation: GeneReviews links SYNE1 deficiency to cerebellar cognitive and affective syndrome.
  - target: Short attention span
    description: >-
      Attentional deficit as a specific domain of the cerebellar cognitive and
      affective syndrome.
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - cerebellar cognitive and affective syndrome
    evidence:
    - reference: PMID:20301553
      reference_title: "SYNE1 Deficiency."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "significant deficits in attention, executive functioning, verbal working memory, and visuospatial/visuoconstructional skills"
      explanation: GeneReviews names attention as an impaired domain within the cerebellar cognitive and affective syndrome.
  - target: Square-wave jerks
    description: Square-wave jerks as part of the cerebellar ocular motor disturbance.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:33526008
      reference_title: "Eye-tracking-aided characterization of saccades and antisaccades in SYNE1 ataxia patients: a pilot study."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "only the occurrence of gaze-evoked nystagmus, slowing of saccades, broken up smooth pursuits, strabismus and square-wave jerks were reported"
      explanation: Square-wave jerks are among the oculomotor findings reported across published SYNE1 ataxia patients.
  - target: Jerky ocular pursuit movements
    description: Broken-up (saccadic) smooth pursuit as part of the cerebellar ocular motor disturbance.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:33526008
      reference_title: "Eye-tracking-aided characterization of saccades and antisaccades in SYNE1 ataxia patients: a pilot study."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "only the occurrence of gaze-evoked nystagmus, slowing of saccades, broken up smooth pursuits, strabismus and square-wave jerks were reported"
      explanation: Broken-up smooth pursuit is among the oculomotor findings reported across published SYNE1 ataxia patients.
  - target: Dysphagia
    description: >-
      Swallowing difficulty accompanying the bulbar/cerebellar motor speech
      disturbance, flagged by GeneReviews for ongoing surveillance.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:20301553
      reference_title: "SYNE1 Deficiency."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "dysarthria, dysphagia, cognition, and psychiatric manifestations"
      explanation: >-
        GeneReviews groups dysphagia with dysarthria among the manifestations to
        be assessed at surveillance visits. The link is indirect because no
        cited source establishes the mechanism connecting cerebellar
        degeneration to swallowing impairment in this disorder.
phenotypes:
- category: Phenotype
  name: Cerebellar ataxia
  description: >-
    Progressive gait and limb ataxia is the cardinal and near-universal feature,
    typically with adult onset (mean ~31.6 years) in the founder phenotype.
  phenotype_term:
    preferred_term: Cerebellar ataxia
    term:
      id: HP:0001251
      label: Ataxia
    clinical_course: PROGRESSIVE
  evidence:
  - reference: PMID:17503513
    reference_title: "Clinical and genetic study of autosomal recessive cerebellar ataxia type 1."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "ARCA-1 is a cerebellar syndrome characterized by recessive transmission, middle-age onset (mean, 31.60; range, 17-46 years), slow progression and moderate disability"
    explanation: Establishes progressive cerebellar ataxia as the core syndrome.
- category: Phenotype
  name: Gait ataxia
  description: Unsteady, ataxic gait, frequently the presenting symptom.
  phenotype_term:
    preferred_term: Gait ataxia
    term:
      id: HP:0002066
      label: Gait ataxia
  evidence:
  - reference: PMID:33526008
    reference_title: "Eye-tracking-aided characterization of saccades and antisaccades in SYNE1 ataxia patients: a pilot study."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "SYNE1 ataxia is an autosomal recessive hereditary condition, the main characteristic features of which are gait and limb ataxia and cerebellar dysarthria."
    explanation: Confirms gait ataxia as a core characteristic feature.
- category: Phenotype
  name: Limb ataxia
  description: Appendicular ataxia affecting limb coordination.
  phenotype_term:
    preferred_term: Limb ataxia
    term:
      id: HP:0002070
      label: Limb ataxia
  evidence:
  - reference: PMID:33526008
    reference_title: "Eye-tracking-aided characterization of saccades and antisaccades in SYNE1 ataxia patients: a pilot study."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "the main characteristic features of which are gait and limb ataxia and cerebellar dysarthria"
    explanation: Confirms limb ataxia as a characteristic feature.
- category: Phenotype
  name: Dysarthria
  description: >-
    Cerebellar dysarthria is one of the features that defines the ARCA1
    syndrome, described as "significant" in the founder cohort.
  phenotype_term:
    preferred_term: Cerebellar dysarthria
    term:
      id: HP:0001260
      label: Dysarthria
  frequency: VERY_FREQUENT
  evidence:
  - reference: PMID:17503513
    reference_title: "Clinical and genetic study of autosomal recessive cerebellar ataxia type 1."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "ARCA-1 is a cerebellar syndrome characterized by recessive transmission, middle-age onset (mean, 31.60; range, 17-46 years), slow progression and moderate disability, significant dysarthria"
    explanation: >-
      Dupre 2007 defines the syndrome as "characterized by ... significant
      dysarthria". No cited source reports a dysarthria numerator/denominator,
      so the VERY_FREQUENT band rests on the qualitative mapping in
      docs/frequency-evidence-guidelines.md, under which a feature named as
      characterizing the syndrome maps to VERY_FREQUENT (80-99%). Downgrade or
      remove the band if a quantitative cohort figure becomes available.
- category: Phenotype
  name: Dysmetria
  description: Impaired coordination of movement amplitude, part of the cerebellar syndrome.
  phenotype_term:
    preferred_term: Dysmetria
    term:
      id: HP:0001310
      label: Dysmetria
  evidence:
  - reference: PMID:20301553
    reference_title: "SYNE1 Deficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "some individuals have a pure cerebellar syndrome (i.e., cerebellar ataxia, dysarthria, dysmetria, abnormalities in ocular saccades and smooth pursuit)"
    explanation: GeneReviews lists dysmetria as part of the pure cerebellar syndrome.
- category: Phenotype
  name: Abnormal ocular smooth pursuit
  description: >-
    Impaired smooth pursuit eye movements, an ocular motor abnormality of the
    cerebellar syndrome.
  phenotype_term:
    preferred_term: Impaired smooth pursuit
    term:
      id: HP:0007772
      label: Impaired smooth pursuit
  evidence:
  - reference: PMID:20301553
    reference_title: "SYNE1 Deficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "abnormalities in ocular saccades and smooth pursuit"
    explanation: GeneReviews documents abnormal ocular saccades and smooth pursuit.
- category: Phenotype
  name: Slow saccades
  description: >-
    Abnormal (slow and/or hypometric) saccadic eye movements documented by eye
    tracking in SYNE1 ataxia patients.
  phenotype_term:
    preferred_term: Slow saccadic eye movements
    term:
      id: HP:0000514
      label: Slow saccadic eye movements
  evidence:
  - reference: PMID:33526008
    reference_title: "Eye-tracking-aided characterization of saccades and antisaccades in SYNE1 ataxia patients: a pilot study."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The eye tracking assessment revealed hypometric saccades in the longer amplitude (18.4°) saccadic paradigm in all SYNE1 patients, whereas 2 out of 3 SYNE1 subjects performed slow saccades as well."
    explanation: Eye-tracking study documents slow and hypometric saccades in SYNE1 ataxia patients.
- category: Phenotype
  name: Nystagmus
  description: Gaze-evoked nystagmus reported as an ocular motor abnormality in SYNE1 ataxia patients.
  phenotype_term:
    preferred_term: Nystagmus
    term:
      id: HP:0000639
      label: Nystagmus
  evidence:
  - reference: PMID:33526008
    reference_title: "Eye-tracking-aided characterization of saccades and antisaccades in SYNE1 ataxia patients: a pilot study."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "only the occurrence of gaze-evoked nystagmus, slowing of saccades, broken up smooth pursuits, strabismus and square-wave jerks were reported"
    explanation: Review of published SYNE1 ataxia patients documents gaze-evoked nystagmus among the reported oculomotor findings.
- category: Phenotype
  name: Cerebellar atrophy
  description: >-
    Diffuse cerebellar atrophy on CT/MRI is a consistent imaging finding, without
    cortical, brainstem, or white-matter involvement in the classic phenotype.
  phenotype_term:
    preferred_term: Cerebellar atrophy
    term:
      id: HP:0001272
      label: Cerebellar atrophy
  evidence:
  - reference: PMID:17503513
    reference_title: "Clinical and genetic study of autosomal recessive cerebellar ataxia type 1."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "normal nerve conduction studies, and diffuse cerebellar atrophy on imaging"
    explanation: Documents diffuse cerebellar atrophy on imaging.
- category: Phenotype
  name: Upper motor neuron dysfunction
  description: >-
    Many SYNE1-deficient patients show upper motor neuron signs, part of the
    broader cerebellar-plus spectrum that extends beyond the relatively pure
    founder phenotype. The component signs are curated separately below.
  phenotype_term:
    preferred_term: Upper motor neuron dysfunction
    term:
      id: HP:0002493
      label: Upper motor neuron dysfunction
  frequency: FREQUENT
  evidence:
  - reference: PMID:20301553
    reference_title: "SYNE1 Deficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "many also have upper motor neuron dysfunction (spasticity, hyperreflexia, Babinski sign) and/or lower motor neuron dysfunction (amyotrophy, reduced reflexes, fasciculations)"
    explanation: >-
      GeneReviews reports that "many" SYNE1-deficient individuals have upper
      motor neuron dysfunction. Per the qualitative mapping in
      docs/frequency-evidence-guidelines.md this maps to FREQUENT (30-79%); no
      cited source gives a numerator/denominator for this arm.
- category: Phenotype
  name: Lower motor neuron involvement (cerebellar-plus)
  description: >-
    Lower motor neuron dysfunction and motor neuron disease features occur in a
    subset of patients, particularly in non-founder cohorts; variants associated
    with motor neuron involvement tend to cluster in the C-terminal region.
  phenotype_term:
    preferred_term: Lower motor neuron dysfunction
    term:
      id: HP:0002366
      label: Abnormal lower motor neuron morphology
  evidence:
  - reference: PMID:32889669
    reference_title: "Autosomal Recessive Cerebellar Ataxia Type 1: Phenotypic and Genetic Correlation in a Cohort of Chinese Patients with SYNE1 Variants."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "four patients exhibited non-cerebellar phenotypes, including motor neuron symptoms, cognitive impairment, or mental retardation"
    explanation: The Chinese cohort documents motor neuron involvement as part of the cerebellar-plus phenotype.
- category: Phenotype
  name: Cognitive impairment
  description: >-
    Cognitive impairment and the cerebellar cognitive and affective syndrome
    (deficits in attention, executive function, verbal working memory,
    visuospatial skills) occur in many patients; intellectual disability is seen
    in childhood-onset multisystem disease.
  phenotype_term:
    preferred_term: Cognitive impairment
    term:
      id: HP:0100543
      label: Cognitive impairment
  evidence:
  - reference: PMID:20301553
    reference_title: "SYNE1 Deficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Most individuals develop features of the cerebellar cognitive and affective syndrome (i.e., significant deficits in attention, executive functioning, verbal working memory, and visuospatial/visuoconstructional skills)."
    explanation: GeneReviews documents the cerebellar cognitive and affective syndrome in most patients.
- category: Phenotype
  name: Short attention span
  description: >-
    Attentional deficit as a component of the cerebellar cognitive and affective
    syndrome.
  phenotype_term:
    preferred_term: Deficits in attention
    term:
      id: HP:0000736
      label: Short attention span
  evidence:
  - reference: PMID:20301553
    reference_title: "SYNE1 Deficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "significant deficits in attention, executive functioning, verbal working memory, and visuospatial/visuoconstructional skills"
    explanation: >-
      GeneReviews names attention as one of the specific domains impaired in the
      cerebellar cognitive and affective syndrome. Curated separately from the
      broader Cognitive impairment entry so the specific HPO term is available.
- category: Phenotype
  name: Spasticity
  description: >-
    Spasticity as a component upper motor neuron sign in the cerebellar-plus
    spectrum.
  phenotype_term:
    preferred_term: Spasticity
    term:
      id: HP:0001257
      label: Spasticity
  evidence:
  - reference: PMID:20301553
    reference_title: "SYNE1 Deficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "many also have upper motor neuron dysfunction (spasticity, hyperreflexia, Babinski sign)"
    explanation: >-
      GeneReviews names spasticity as a component of the upper motor neuron
      arm. No frequency band is asserted: the source quantifies the upper motor
      neuron arm as a whole ("many"), not each component sign.
- category: Phenotype
  name: Hyperreflexia
  description: Hyperreflexia as a component upper motor neuron sign.
  phenotype_term:
    preferred_term: Hyperreflexia
    term:
      id: HP:0001347
      label: Hyperreflexia
  evidence:
  - reference: PMID:20301553
    reference_title: "SYNE1 Deficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "many also have upper motor neuron dysfunction (spasticity, hyperreflexia, Babinski sign)"
    explanation: >-
      GeneReviews names hyperreflexia as a component of the upper motor neuron
      arm. No frequency band is asserted for the individual sign.
- category: Phenotype
  name: Lower limb hyperreflexia
  description: >-
    Brisk lower-extremity reflexes, the specific upper motor neuron sign
    reported in the Beauce founder cohort, where the phenotype is otherwise
    relatively pure cerebellar.
  phenotype_term:
    preferred_term: Brisk lower extremity reflexes
    term:
      id: HP:0002395
      label: Lower limb hyperreflexia
  frequency: OCCASIONAL
  evidence:
  - reference: PMID:17503513
    reference_title: "Clinical and genetic study of autosomal recessive cerebellar ataxia type 1."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "occasional brisk reflexes in the lower extremities"
    explanation: >-
      Dupre 2007 reports brisk lower-extremity reflexes in the founder cohort.
      The author term "occasional" maps to OCCASIONAL (5-29%) under the
      qualitative mapping in docs/frequency-evidence-guidelines.md.
- category: Phenotype
  name: Babinski sign
  description: Extensor plantar response as a component upper motor neuron sign.
  phenotype_term:
    preferred_term: Babinski sign
    term:
      id: HP:0003487
      label: Babinski sign
  evidence:
  - reference: PMID:20301553
    reference_title: "SYNE1 Deficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "many also have upper motor neuron dysfunction (spasticity, hyperreflexia, Babinski sign)"
    explanation: >-
      GeneReviews names the Babinski sign as a component of the upper motor
      neuron arm. No frequency band is asserted for the individual sign.
- category: Phenotype
  name: Skeletal muscle atrophy
  description: >-
    Amyotrophy as a component lower motor neuron sign in the cerebellar-plus
    spectrum.
  phenotype_term:
    preferred_term: Amyotrophy
    term:
      id: HP:0003202
      label: Skeletal muscle atrophy
  evidence:
  - reference: PMID:20301553
    reference_title: "SYNE1 Deficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "lower motor neuron dysfunction (amyotrophy, reduced reflexes, fasciculations)"
    explanation: >-
      GeneReviews names amyotrophy as a component of the lower motor neuron
      arm. No frequency band is asserted for the individual sign.
- category: Phenotype
  name: Reduced tendon reflexes
  description: >-
    Reduced deep tendon reflexes as a component lower motor neuron sign,
    contrasting with the brisk reflexes seen in the upper motor neuron arm.
  phenotype_term:
    preferred_term: Reduced tendon reflexes
    term:
      id: HP:0001315
      label: Reduced tendon reflexes
  evidence:
  - reference: PMID:20301553
    reference_title: "SYNE1 Deficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "lower motor neuron dysfunction (amyotrophy, reduced reflexes, fasciculations)"
    explanation: >-
      GeneReviews names reduced reflexes as a component of the lower motor
      neuron arm. No frequency band is asserted for the individual sign.
- category: Phenotype
  name: Fasciculations
  description: Fasciculations as a component lower motor neuron sign.
  phenotype_term:
    preferred_term: Fasciculations
    term:
      id: HP:0002380
      label: Fasciculations
  evidence:
  - reference: PMID:20301553
    reference_title: "SYNE1 Deficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "lower motor neuron dysfunction (amyotrophy, reduced reflexes, fasciculations)"
    explanation: >-
      GeneReviews names fasciculations as a component of the lower motor neuron
      arm. No frequency band is asserted for the individual sign.
- category: Phenotype
  name: Dysphagia
  description: >-
    Swallowing difficulty, named by GeneReviews as a domain requiring ongoing
    surveillance in SYNE1 deficiency.
  phenotype_term:
    preferred_term: Dysphagia
    term:
      id: HP:0002015
      label: Dysphagia
  evidence:
  - reference: PMID:20301553
    reference_title: "SYNE1 Deficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "dysarthria, dysphagia, cognition, and psychiatric manifestations"
    explanation: >-
      GeneReviews lists dysphagia among the manifestations to be assessed at
      surveillance visits, implying it occurs in the disorder. This is an
      indirect assertion; no cited source reports its frequency.
- category: Phenotype
  name: Square-wave jerks
  description: Square-wave jerks among the oculomotor abnormalities reported in SYNE1 ataxia.
  phenotype_term:
    preferred_term: Square-wave jerks
    term:
      id: HP:0025402
      label: Square-wave jerks
  evidence:
  - reference: PMID:33526008
    reference_title: "Eye-tracking-aided characterization of saccades and antisaccades in SYNE1 ataxia patients: a pilot study."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "only the occurrence of gaze-evoked nystagmus, slowing of saccades, broken up smooth pursuits, strabismus and square-wave jerks were reported"
    explanation: >-
      A review of 168 previously published SYNE1 ataxia patients lists
      square-wave jerks among the reported oculomotor findings. The sentence is
      a summary of prior literature, not a new observation in this cohort.
- category: Phenotype
  name: Jerky ocular pursuit movements
  description: >-
    Broken-up (saccadic) smooth pursuit, the specific pursuit abnormality
    reported in the SYNE1 ataxia literature.
  phenotype_term:
    preferred_term: Broken up smooth pursuit
    term:
      id: HP:0008003
      label: Jerky ocular pursuit movements
  evidence:
  - reference: PMID:33526008
    reference_title: "Eye-tracking-aided characterization of saccades and antisaccades in SYNE1 ataxia patients: a pilot study."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "only the occurrence of gaze-evoked nystagmus, slowing of saccades, broken up smooth pursuits, strabismus and square-wave jerks were reported"
    explanation: >-
      Adds the specific HPO term for broken-up smooth pursuit alongside the
      broader Abnormal ocular smooth pursuit entry. Summary of prior literature.
- category: Phenotype
  name: Strabismus
  description: Strabismus among the ocular findings reported in SYNE1 ataxia.
  phenotype_term:
    preferred_term: Strabismus
    term:
      id: HP:0000486
      label: Strabismus
  evidence:
  - reference: PMID:33526008
    reference_title: "Eye-tracking-aided characterization of saccades and antisaccades in SYNE1 ataxia patients: a pilot study."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "only the occurrence of gaze-evoked nystagmus, slowing of saccades, broken up smooth pursuits, strabismus and square-wave jerks were reported"
    explanation: >-
      A review of previously published SYNE1 ataxia patients lists strabismus
      among the reported ocular findings. Summary of prior literature.
- category: Phenotype
  name: Scoliosis
  description: >-
    Scoliosis as a non-neurological feature of the extracerebellar SYNE1
    phenotype seen in non-founder cohorts.
  phenotype_term:
    preferred_term: Scoliosis
    term:
      id: HP:0002650
      label: Scoliosis
  evidence:
  - reference: PMID:33526008
    reference_title: "Eye-tracking-aided characterization of saccades and antisaccades in SYNE1 ataxia patients: a pilot study."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "non-neurological abnormalities, including scoliosis, pes cavus or respiratory dysfunction with severe manifestation"
    explanation: >-
      Describes the non-Canadian SYNE1 ataxia cohort, in which most patients had
      extracerebellar signs including scoliosis.
- category: Phenotype
  name: Pes cavus
  description: >-
    Pes cavus as a non-neurological feature of the extracerebellar SYNE1
    phenotype seen in non-founder cohorts.
  phenotype_term:
    preferred_term: Pes cavus
    term:
      id: HP:0001761
      label: Pes cavus
  evidence:
  - reference: PMID:33526008
    reference_title: "Eye-tracking-aided characterization of saccades and antisaccades in SYNE1 ataxia patients: a pilot study."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "non-neurological abnormalities, including scoliosis, pes cavus or respiratory dysfunction with severe manifestation"
    explanation: >-
      Describes the non-Canadian SYNE1 ataxia cohort, in which most patients had
      extracerebellar signs including pes cavus.
- category: Phenotype
  name: Respiratory dysfunction
  description: >-
    Respiratory dysfunction reported in severely affected patients outside the
    founder population.
  phenotype_term:
    preferred_term: Respiratory dysfunction
    term:
      id: HP:0002086
      label: Abnormality of the respiratory system
  evidence:
  - reference: PMID:33526008
    reference_title: "Eye-tracking-aided characterization of saccades and antisaccades in SYNE1 ataxia patients: a pilot study."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "non-neurological abnormalities, including scoliosis, pes cavus or respiratory dysfunction with severe manifestation"
    explanation: >-
      Reports respiratory dysfunction as a severe-end extracerebellar
      manifestation. The HPO term is deliberately broad because the source does
      not specify the respiratory abnormality.
- category: Phenotype
  name: Intellectual disability
  subtype: Childhood-onset multisystem
  description: >-
    Intellectual disability is part of the childhood-onset multisystem
    presentation, not the adult-onset Beauce founder phenotype.
  phenotype_term:
    preferred_term: Intellectual disability
    term:
      id: HP:0001249
      label: Intellectual disability
  evidence:
  - reference: PMID:20301553
    reference_title: "SYNE1 Deficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "SYNE1-deficient childhood-onset multisystem disease (ataxia, upper and lower motor neuron dysfunction, muscle weakness and wasting, intellectual disability)"
    explanation: >-
      GeneReviews scopes intellectual disability to the childhood-onset
      multisystem phenotype, which is why this entry carries a subtype
      qualifier rather than being asserted of the disease as a whole.
- category: Phenotype
  name: Muscle weakness
  subtype: Childhood-onset multisystem
  description: >-
    Muscle weakness and wasting in the childhood-onset multisystem presentation.
  phenotype_term:
    preferred_term: Muscle weakness and wasting
    term:
      id: HP:0001324
      label: Muscle weakness
  evidence:
  - reference: PMID:20301553
    reference_title: "SYNE1 Deficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "SYNE1-deficient childhood-onset multisystem disease (ataxia, upper and lower motor neuron dysfunction, muscle weakness and wasting, intellectual disability)"
    explanation: >-
      GeneReviews scopes muscle weakness and wasting to the childhood-onset
      multisystem phenotype.
- category: Phenotype
  name: Decreased fetal movement
  subtype: AMC
  description: >-
    Decreased fetal movements at the severe (arthrogryposis) end of the SYNE1
    deficiency spectrum.
  phenotype_term:
    preferred_term: Decreased fetal movement
    term:
      id: HP:0001558
      label: Decreased fetal movement
  evidence:
  - reference: PMID:20301553
    reference_title: "SYNE1 Deficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "SYNE1-deficient arthrogryposis multiplex congenita (decreased fetal movements and severe neonatal hypotonia associated with multiple congenital joint contractures including clubfoot)"
    explanation: >-
      GeneReviews scopes decreased fetal movements to the arthrogryposis
      multiplex congenita phenotype at the severe end of the spectrum.
- category: Phenotype
  name: Neonatal hypotonia
  subtype: AMC
  description: Severe neonatal hypotonia in the arthrogryposis presentation.
  phenotype_term:
    preferred_term: Severe neonatal hypotonia
    term:
      id: HP:0001319
      label: Neonatal hypotonia
    severity: SEVERE
  evidence:
  - reference: PMID:20301553
    reference_title: "SYNE1 Deficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "decreased fetal movements and severe neonatal hypotonia associated with multiple congenital joint contractures including clubfoot"
    explanation: >-
      GeneReviews scopes severe neonatal hypotonia to the arthrogryposis
      multiplex congenita phenotype.
- category: Phenotype
  name: Arthrogryposis multiplex congenita
  subtype: AMC
  description: >-
    Multiple congenital joint contractures define the severe end of the SYNE1
    deficiency spectrum.
  phenotype_term:
    preferred_term: Arthrogryposis multiplex congenita
    term:
      id: HP:0002804
      label: Arthrogryposis multiplex congenita
  evidence:
  - reference: PMID:20301553
    reference_title: "SYNE1 Deficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "SYNE1 deficiency comprises a phenotypic spectrum that ranges from autosomal recessive cerebellar ataxia at the mild end to arthrogryposis multiplex congenita (AMC) at the severe end."
    explanation: >-
      GeneReviews places arthrogryposis multiplex congenita at the severe end of
      the SYNE1 deficiency spectrum, anchoring the AMC subtype.
- category: Phenotype
  name: Talipes equinovarus
  subtype: AMC
  description: Clubfoot as one of the congenital joint contractures in the AMC presentation.
  phenotype_term:
    preferred_term: Clubfoot
    term:
      id: HP:0001762
      label: Talipes equinovarus
  evidence:
  - reference: PMID:20301553
    reference_title: "SYNE1 Deficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "multiple congenital joint contractures including clubfoot"
    explanation: >-
      GeneReviews names clubfoot among the congenital contractures of the
      arthrogryposis phenotype.
genetic:
- name: Biallelic SYNE1 pathogenic variants
  gene_term:
    preferred_term: SYNE1
    term:
      id: hgnc:17089
      label: SYNE1
  inheritance:
  - name: Autosomal recessive inheritance
    inheritance_term:
      preferred_term: Autosomal recessive inheritance
      term:
        id: HP:0000007
        label: Autosomal recessive inheritance
    evidence:
    - reference: PMID:20301553
      reference_title: "SYNE1 Deficiency."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "SYNE1 deficiency is inherited in an autosomal recessive manner. The parents of an affected individual are obligate heterozygotes"
      explanation: GeneReviews establishes autosomal recessive inheritance for SYNE1 deficiency.
  notes: >-
    The diagnosis is established by identification of biallelic SYNE1 pathogenic
    variants. SYNE1 is one of the largest human genes, and disease-associated
    variants are enriched for truncating loss-of-function alleles spread throughout
    the gene; large intragenic deletions detectable only by CNV-sensitive methods
    also occur. In Quebec founder families, a recurrent allele accounts for roughly
    half of carrier chromosomes.
  evidence:
  - reference: PMID:20301553
    reference_title: "SYNE1 Deficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The diagnosis of SYNE1 deficiency is established in a proband with suggestive findings and biallelic SYNE1 pathogenic variants identified by molecular genetic testing."
    explanation: GeneReviews defines the molecular diagnostic basis as biallelic SYNE1 variants.
  - reference: PMID:32889669
    reference_title: "Autosomal Recessive Cerebellar Ataxia Type 1: Phenotypic and Genetic Correlation in a Cohort of Chinese Patients with SYNE1 Variants."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We identified eight truncating variants and two missense variants spreading throughout the SYNE1 gene from six unrelated families"
    explanation: Documents the predominance of truncating SYNE1 variants distributed across the gene.
treatments:
- name: Supportive and Rehabilitative Care
  description: >-
    There is no specific or disease-modifying treatment for SYNE1 deficiency.
    Management is supportive, aiming to maximize function and reduce complications
    through a multidisciplinary team (neurology, physical/occupational/speech
    therapy, physiatry, orthopedics, nutrition).
  treatment_term:
    preferred_term: supportive care
    term:
      id: NCIT:C15747
      label: Supportive Care
  evidence:
  - reference: PMID:20301553
    reference_title: "SYNE1 Deficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "There is no specific treatment for SYNE1 deficiency. The goals of treatment are to maximize function and reduce complications."
    explanation: GeneReviews states management is supportive with no specific therapy.
- name: Physical Therapy
  description: Rehabilitation to maintain mobility and address ataxia, spasticity, and weakness.
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: Physical Therapy
    term:
      id: NCIT:C15302
      label: Physical Therapy
  evidence:
  - reference: PMID:20301553
    reference_title: "SYNE1 Deficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "managed by a multidisciplinary team of relevant specialists including neurologists, occupational therapists, physical therapists, physiatrists, orthopedists, nutritionists, speech therapists, respiratory therapists, and psychologists"
    explanation: GeneReviews recommends physical therapy within multidisciplinary management.
- name: Speech Therapy
  description: Speech therapy for cerebellar dysarthria and, when present, dysphagia.
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: speech therapy
    term:
      id: NCIT:C159273
      label: Speech Language Therapy
  evidence:
  - reference: PMID:20301553
    reference_title: "SYNE1 Deficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "neurologists, occupational therapists, physical therapists, physiatrists, orthopedists, nutritionists, speech therapists, respiratory therapists, and psychologists"
    explanation: GeneReviews includes speech therapy within multidisciplinary management.
- name: Genetic Counseling
  description: >-
    Genetic counseling is indicated given autosomal recessive inheritance; carrier
    testing, prenatal diagnosis, and preimplantation genetic testing are available
    once familial variants are known. Relevant in founder populations.
  treatment_term:
    preferred_term: Genetic Counseling
    term:
      id: NCIT:C15240
      label: Genetic Counseling
  evidence:
  - reference: PMID:20301553
    reference_title: "SYNE1 Deficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "carrier testing for at-risk relatives, prenatal diagnosis for a pregnancy at increased risk, and preimplantation genetic testing are possible"
    explanation: GeneReviews supports genetic counseling and reproductive testing options.
prevalence:
- population: Eastern Quebec adults
  measure_type: POINT_PREVALENCE
  prevalence_class: BAND_1_9_PER_100000
  rate_per_100000: 2.67
  notes: >-
    In an Eastern Quebec cross-sectional study, ARCA1 (AR cerebellar ataxia type 1)
    was the most prevalent hereditary ataxia identified, at a minimum prevalence of
    2.67/100,000 [95% CI 2.65-2.7], within an overall adult hereditary ataxia
    prevalence of 6.47/100,000. This is a founder-population figure and a
    *minimum* (genetically confirmed cases only); it should not be read as a
    worldwide prevalence for this disorder, and no worldwide estimate is
    currently curated.
  evidence:
  - reference: PMID:33397523
    reference_title: "Genetic and Epidemiological Study of Adult Ataxia and Spastic Paraplegia in Eastern Quebec."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "AR cerebellar ataxia type 1 (2.67/100 000) and AD spastic paraplegia SPG4 (1.18/100 000) were the most prevalent disorders identified."
    explanation: Provides a population-based minimum prevalence estimate for ARCA1.
progression:
- phase: Adult-onset cerebellar syndrome
  age_range: Adolescence to mid-adulthood (range ~6-45 years; mean onset ~31.6 years in founder cohort)
  notes: >-
    Classic Beauce phenotype begins with gait and limb ataxia in early-to-mid
    adulthood, with dysarthria following. Non-founder cohorts can show earlier
    (childhood/young-adult) onset.
  evidence:
  - reference: PMID:20301553
    reference_title: "SYNE1 Deficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "SYNE1-deficient cerebellar ataxia, the most commonly recognized manifestation of SYNE1 deficiency to date, is a slowly progressive disorder typically beginning in adulthood (age range 6-45 years)."
    explanation: GeneReviews documents typical adult onset across a wide age range.
- phase: Slowly progressive course
  duration: Slowly progressive over years to decades
  notes: >-
    The founder phenotype progresses slowly to moderate disability with no effect
    on life expectancy; cerebellar-plus forms can carry additional morbidity from
    motor neuron and multisystem involvement.
  evidence:
  - reference: PMID:17503513
    reference_title: "Clinical and genetic study of autosomal recessive cerebellar ataxia type 1."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "recessive transmission, middle-age onset (mean, 31.60; range, 17-46 years), slow progression and moderate disability"
    explanation: Documents slow progression to moderate disability.
diagnosis:
- name: Brain MRI
  description: >-
    Brain MRI demonstrating diffuse cerebellar atrophy supports the diagnosis;
    normal nerve conduction studies help distinguish ARCA1 from ataxias with
    prominent peripheral neuropathy.
  evidence:
  - reference: PMID:17503513
    reference_title: "Clinical and genetic study of autosomal recessive cerebellar ataxia type 1."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "normal nerve conduction studies, and diffuse cerebellar atrophy on imaging"
    explanation: Imaging shows diffuse cerebellar atrophy with normal nerve conduction.
- name: Molecular genetic testing (NGS with CNV analysis)
  description: >-
    Next-generation sequencing (gene panel, exome, or genome) detects most SYNE1
    variants, but CNV-sensitive methods (e.g., array-CGH) are needed to detect
    large intragenic deletions that standard sequencing pipelines may miss.
    Diagnostic workup for adult-onset hereditary ataxia combines STR-expansion
    testing with sequencing.
  evidence:
  - reference: PMID:38136976
    reference_title: "A Case Report of SYNE1 Deficiency-Mimicking Mitochondrial Disease and the Value of Pangenomic Investigations."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "even rare copy number variations should be considered in patients with a phenotype suggestive of SYNE1 deficiency"
    explanation: Highlights the need for CNV-sensitive testing in suspected SYNE1 deficiency.
  - reference: PMID:38760634
    reference_title: "An update on the adult-onset hereditary cerebellar ataxias: novel genetic causes and new diagnostic approaches."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Testing methods include targeted evaluation of STR expansions (e.g. SCAs, Friedreich ataxia, fragile X-associated tremor/ataxia syndrome, dentatorubral-pallidoluysian atrophy), next generation sequencing for conventional variants, which may include targeted gene panels, whole exome, or whole genome sequencing"
    explanation: Describes the contemporary diagnostic approach for adult-onset hereditary ataxia.
differential_diagnoses:
- name: Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS)
  disease_term:
    preferred_term: ARSACS
    term:
      id: MONDO:0010041
      label: Charlevoix-Saguenay spastic ataxia
  description: >-
    The most important differential in the population where ARCA1 was defined:
    a second recessive ataxia with a Quebec founder effect, present in the same
    Eastern Quebec ataxia clinics. Both are recessive, both are cerebellar, and
    both are enriched in the same ancestry, so ancestry alone does not
    discriminate them.
  distinguishing_features:
  - Caused by biallelic SACS variants (sacsin), not SYNE1.
  - Prominent spasticity and peripheral neuropathy, whereas ARCA1 has normal nerve conduction studies and is relatively pure cerebellar.
  - Roughly six-fold rarer than ARCA1 in the same Eastern Quebec population (0.43 vs 2.67 per 100,000).
  evidence:
  - reference: PMID:33397523
    reference_title: "Genetic and Epidemiological Study of Adult Ataxia and Spastic Paraplegia in Eastern Quebec."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Pathogenic mutations in SACS were found in seven non-related patients"
    explanation: >-
      Establishes that SACS-related ARSACS co-occurs with ARCA1 in the same
      Eastern Quebec cohort, making it the co-located differential.
- name: Friedreich ataxia
  disease_term:
    preferred_term: Friedreich ataxia
    term:
      id: MONDO:0100339
      label: Friedreich ataxia
  description: >-
    The commonest recessive ataxia overall and the comparator against which
    SYNE1 oculomotor findings have been benchmarked.
  distinguishing_features:
  - Caused by a GAA repeat expansion in FXN, detected by repeat-expansion testing rather than sequencing.
  - Sensory axonal neuropathy with absent reflexes; ARCA1 has normal nerve conduction studies.
  - Cardiomyopathy and diabetes are part of Friedreich ataxia and are not features of the ARCA1 founder phenotype.
  evidence:
  - reference: PMID:33526008
    reference_title: "Eye-tracking-aided characterization of saccades and antisaccades in SYNE1 ataxia patients: a pilot study."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "compare them to the same parameters of Friedreich ataxia (FA) patients and healthy subjects"
    explanation: >-
      Friedreich ataxia is used as the explicit clinical comparator group in the
      SYNE1 oculomotor study, reflecting its role as the primary differential.
- name: Primary mitochondrial disease
  description: >-
    SYNE1 deficiency can present with secondary mitochondrial findings and be
    misclassified as a primary mitochondrial disorder, a diagnostic trap worth
    recording explicitly because it redirects the whole testing strategy.
  distinguishing_features:
  - COX-negative fibers and mtDNA deletions can be present in SYNE1 deficiency as secondary findings.
  - Resolution requires pangenomic (exome plus CNV-sensitive) testing rather than mitochondrial-targeted testing.
  evidence:
  - reference: PMID:38136976
    reference_title: "A Case Report of SYNE1 Deficiency-Mimicking Mitochondrial Disease and the Value of Pangenomic Investigations."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The proband presented with the association of cerebellar ataxia, COX-negative fibers on muscle histology, and mtDNA deletions."
    explanation: >-
      Documents a SYNE1-deficient proband whose muscle and mtDNA findings
      pointed toward a primary mitochondrial disorder before exome sequencing
      plus array-CGH identified biallelic SYNE1 variants.
discussions:
- discussion_id: syne1_proximal_cerebellar_target
  kind: OPEN_QUESTION
  status: UNDER_DISCUSSION
  prompt: >-
    Which cerebellar cell population is the proximal target of SYNE1 loss — the
    Purkinje cell nuclear envelope, as the canonical LINC model and this entry's
    pathograph assume, or the mossy-fibre/granule-cell synaptic compartment
    where the cerebellum-enriched KASH-less nesprin-1 isoform actually
    localizes?
  attaches_to:
  - pathophysiology#Disrupted Nuclear-Cytoskeletal LINC Coupling
  - pathophysiology#Cerebellar Neurodegeneration and Atrophy
  rationale: >-
    This entry asserts Purkinje-cell vulnerability in its pathograph and
    declares conformance to
    cerebellar_purkinje_degeneration#Purkinje Neuron Degeneration, which is the
    mainstream reading of GeneReviews and of Dupre's statement that SYNE1 is
    critical to the maintenance of cerebellar structure. Neither of those
    sources actually demonstrates Purkinje neuron loss. The direct localization
    work points the other way: the abundant cerebellar isoform, KLNes1g, is
    KASH-less, sits at mossy-fibre glomeruli and granule-cell dendritic
    membranes rather than the nuclear envelope, and it is Nesprin2 - not
    Nesprin1 - that decorates the nuclear envelope of cerebellar neurons. If
    that is the operative lesion, the cell-type annotations and the module
    conformance on the degeneration node are describing the wrong compartment,
    and the canonical LINC framing is downstream of, or parallel to, the real
    mechanism rather than upstream of it.
  proposed_experiments:
  - experiment_id: exp_syne1_purkinje_vs_granule_neuropathology
    name: Neuropathological series quantifying Purkinje versus granule cell loss
    description: >-
      Assemble a systematic autopsy series of genetically confirmed SYNE1
      ataxia and quantify Purkinje versus granule cell loss and mossy-fibre
      glomerular pathology against age-matched controls. Human neuropathology
      currently rests on isolated case reports, so the entry's Purkinje-centric
      cell-type annotation is not presently testable against a series.
    supporting_outcome:
    - Selective Purkinje neuron loss out of proportion to granule cell loss.
    refuting_outcome:
    - Granule cell or mossy-fibre pathology predominating with relatively preserved Purkinje populations.
  - experiment_id: exp_syne1_celltype_specific_ablation
    name: Cell-type-specific Syne1 ablation in mouse
    description: >-
      Ablate Syne1 selectively in Purkinje cells versus granule cells in mouse
      and compare ataxia severity and cerebellar histology, to establish which
      population is sufficient to produce the phenotype.
    supporting_outcome:
    - Purkinje-restricted ablation reproducing ataxia.
    refuting_outcome:
    - Only granule-cell-restricted ablation reproducing ataxia.
  - experiment_id: exp_klnes1g_human_cerebellum_localization
    name: KASH-less nesprin-1 isoform expression in human cerebellum
    description: >-
      Determine whether the KASH-less nesprin-1 isoform is expressed and
      similarly localized in human cerebellum. The existing splicing and
      immunogold localization data are from mouse, so the translational
      validity of the synaptic model to human disease is untested.
    supporting_outcome:
    - Detection of the KASH-less isoform at human mossy-fibre glomeruli.
    refuting_outcome:
    - Absence of the isoform, or exclusively nuclear-envelope localization, in human cerebellum.
  notes: >-
    Recorded during the 2026-08 publication-readiness review. The conformance
    and the Purkinje cell_types annotations are deliberately retained as the
    mainstream model rather than removed, but they should not be read as
    evidence-backed claims about the proximal cellular target. PMID:36525394
    (an autopsied SYNE1-ataxia patient) is listed under references as a
    bibliographic pointer only and is deliberately not cited as evidence
    anywhere in this entry: PubMed carries no abstract for that letter, so no
    snippet can be verified against a cached source. Mine it for evidence if
    full text ever reaches the cache.
review_notes: >-
  Publication-readiness review, August 2026. Baseline was already schema-valid
  with 100% recommended-field compliance and 46/46 verified snippets, so this
  pass targeted content completeness and claim-evidence alignment rather than
  structure. Changes: added the three GeneReviews-defined presentations as
  has_subtypes so severe-end features can be curated without leaking into the
  adult-onset Beauce founder phenotype; added 21 source-backed phenotypes and
  wired every one of them into the pathograph; declared conformance to
  cerebellar_purkinje_degeneration; tagged biological_scale; converted the
  free-text prevalence record to the structured measure_type/prevalence_class/
  rate_per_100000 slots; and added differential diagnoses. Snippet count went
  46 -> 96, all verified.

  Claim-evidence alignment fixes. (1) The EMERGING synaptic-isoform hypothesis
  was supported only by a generic LINC-complex review whose quoted sentence
  never mentions an isoform; it now cites the primary source (PMID:25843669)
  for both the KASH-less cerebellar isoform and its synaptic localization.
  (2) Dysarthria claimed "present in essentially all patients in the founder
  cohort" and a VERY_FREQUENT band that no source quantified; the description
  now tracks what Dupre actually wrote and the band is explicitly justified as
  a qualitative mapping. (3) The FREQUENT band on upper motor neuron
  dysfunction is likewise now tied to the source word "many". (4) Component
  motor-neuron signs are curated WITHOUT frequency bands, because the source
  quantifies the UMN and LMN arms as wholes and not the individual signs.
  (5) The prevalence record now states that 2.67/100,000 is a minimum
  founder-population figure and not a worldwide rate.

  Dispositions for the 19 remaining D2P recommendations, none of which are
  adopted in this pass:

  - Peripheral-neuropathy cluster (HP:0003477 peripheral axonal neuropathy,
    HP:0003390 sensory axonal neuropathy, HP:0007267 chronic axonal
    neuropathy, HP:0007178 motor polyneuropathy, HP:0001271 polyneuropathy,
    HP:0003445 EMG neuropathic changes, HP:0002495 impaired vibratory
    sensation). NOT ADDED, deliberately. The ARCA1 founder phenotype is
    defined in part by normal nerve conduction studies, and normal NCS is what
    separates it from Friedreich ataxia and ARSACS in the differential above.
    OMIM/Orphanet carry these at Very rare/Occasional, presumably from
    non-founder SYNE1 cohorts. Adding them unqualified would contradict the
    entry's own definition; adding them qualified needs a cohort source that
    reports neuropathy in genetically confirmed SYNE1 patients, which is not
    in the cache. Revisit with such a source.
  - Skeletal/ocular items (HP:0002808 kyphosis, HP:0000508 ptosis, HP:0000597
    ophthalmoparesis, HP:0031960 arm dystonia, HP:0000020 urinary
    incontinence, HP:0002312 clumsiness, HP:0007366 brainstem atrophy,
    HP:0002500 abnormal cerebral white matter, HP:0001270 motor delay). NOT
    ADDED: no cached source supports any of them with a quotable snippet, and
    HP:0002500 and HP:0007366 additionally sit against this entry's curated
    claim that the classic phenotype shows cerebellar atrophy without
    brainstem or white-matter involvement. Fetch primary sources before
    adopting.
  - Broader-term flags (HP:0002061 lower limb spasticity vs curated HP:0001257
    spasticity; HP:0007340 lower limb muscle weakness vs curated HP:0001324
    muscle weakness; HP:0011448 ankle clonus under HP:0002493). NOT
    NARROWED: GeneReviews names spasticity and muscle weakness without limb
    localization, so the broader terms are what the evidence actually supports.
    Narrowing would assert a distribution no cited source states. Ankle clonus
    is not named in any cached source.

  Also unresolved and worth flagging beyond this entry: `just refresh-orphadata`
  currently fails a checksum check against the pinned manifest (upstream
  Orphadata has drifted), so ORPHA:88644 could not be cached and Orphanet
  frequency rows were unavailable as evidence for this review. That blocks
  Orphanet-backed frequency curation repo-wide, not just here.
datasets: []
📚

References & Deep Research

References

2
SYNE1 Deficiency.
No top-level findings curated for this source.
SYNE1-ataxia: clinicopathologic features of an autopsied patient with novel compound heterozygous mutations.
No top-level findings curated for this source.

Deep Research

1
Falcon
Autosomal Recessive Ataxia Beauce Type (ARCA1 / SCAR8 / ATX‑SYNE1): Comprehensive Disease Characteristics Report
Edison Scientific Literature 27 citations 2026-06-04T11:45:34.278886

Autosomal Recessive Ataxia Beauce Type (ARCA1 / SCAR8 / ATX‑SYNE1): Comprehensive Disease Characteristics Report

Executive summary

Autosomal recessive ataxia Beauce type is a SYNE1-related, autosomal recessive hereditary cerebellar ataxia originally described in French-Canadian families from the Beauce and Bas–St‑Laurent regions of Quebec and now recognized worldwide with a broader “cerebellar-plus” spectrum. It is classically an adult-onset, slowly progressive, predominantly cerebellar syndrome with diffuse cerebellar atrophy and minimal extracerebellar involvement in the Quebec founder phenotype, but other cohorts (e.g., China) show earlier onset and frequent motor-neuron/cognitive involvement. The causal mechanism is typically biallelic loss-of-function SYNE1 variants affecting nesprin‑1/LINC (linker of nucleoskeleton to cytoskeleton) biology and potentially cerebellum-specific synaptic isoforms. (dupre2007clinicalandgenetic pages 2-3, duan2021autosomalrecessivecerebellar pages 1-2, kuwako2024diverserolesof pages 11-12)


1. Disease information

1.1 Overview / definition

  • Disease concept: SYNE1-related autosomal recessive cerebellar ataxia characterized by progressive gait and limb ataxia and cerebellar dysarthria, with cerebellar atrophy on neuroimaging; originally described as a cluster in the Beauce region (Quebec) and mapped to SYNE1 at 6q. (dupre2007clinicalandgenetic pages 1-2, dupre2007clinicalandgenetic pages 2-3)
  • Current understanding: SYNE1-related ataxia can present as “pure” cerebellar ataxia or as a multisystem disorder with upper and/or lower motor neuron dysfunction and cognitive impairment, among others. (serag2023acasereport pages 1-2, duan2021autosomalrecessivecerebellar pages 2-4)

1.2 Key identifiers (available from retrieved evidence)

  • OMIM / MIM (disease): 610743 (ARCA1/SCAR8/recessive ataxia of Beauce). (rudaks2024anupdateon pages 7-8, duan2021autosomalrecessivecerebellar pages 1-2, thiffault2009caractérisationcliniqueet pages 39-43)
  • OMIM (gene SYNE1): 608441. (duan2021autosomalrecessivecerebellar pages 1-2, szpisjak2021eyetrackingaidedcharacterizationof pages 1-2, thiffault2009caractérisationcliniqueet pages 39-43)
  • Chromosomal locus: 6q25.2 (gene-based nomenclature table). (rudaks2024anupdateon pages 7-8)

1.3 Synonyms / alternative names

  • Autosomal recessive cerebellar ataxia type 1 (ARCA1) (duan2021autosomalrecessivecerebellar pages 1-2, thiffault2009caractérisationcliniqueet pages 39-43)
  • Spinocerebellar ataxia, autosomal recessive 8 (SCAR8) (duan2021autosomalrecessivecerebellar pages 1-2, szpisjak2021eyetrackingaidedcharacterizationof pages 1-2)
  • Recessive ataxia of Beauce / Beauce ataxia (rudaks2024anupdateon pages 7-8, szpisjak2021eyetrackingaidedcharacterizationof pages 1-2)
  • ATX‑SYNE1 (proposed gene-based nomenclature in adult-onset HCA review) (rudaks2024anupdateon pages 7-8)

1.4 Resource provenance

The evidence summarized here is derived primarily from: - Aggregated disease-level research cohorts (Eastern Quebec epidemiology; Chinese cohort). (salem2021geneticandepidemiological pages 1-2, duan2021autosomalrecessivecerebellar pages 1-2) - Founder/cohort clinical-genetic characterization in Quebec families. (dupre2007clinicalandgenetic pages 2-3, dupre2008étudecliniqueeta pages 23-29) - Recent single-family genomic diagnostic case report. (serag2023acasereport pages 1-2)

1.5 Identifiers not confirmed in the retrieved corpus

  • MONDO ID, Orphanet ID, MeSH term, ICD‑10/ICD‑11 codes: not found in the retrieved full texts; these typically require direct lookup in ontology/databases rather than primary papers. (rudaks2024anupdateon pages 7-8, szpisjak2021eyetrackingaidedcharacterizationof pages 1-2)

2. Etiology

2.1 Disease causal factors

  • Primary cause: biallelic pathogenic variants in SYNE1 (nesprin‑1), most commonly truncating loss-of-function variants, cause ARCA1/SCAR8. (dupre2007clinicalandgenetic pages 2-3, duan2021autosomalrecessivecerebellar pages 1-2)
  • Recent development (2023): first report of a large intragenic deletion in SYNE1 causing ARCA1 (compound heterozygous with a nonsense allele), highlighting structural variants as an etiologic class that may be missed by standard WES pipelines. (serag2023acasereport pages 4-5, serag2023acasereport pages 1-2)

Direct abstract quote (2023 case report): “Whole exome sequencing (WES), supplemented by a high-resolution array… allowed us to identify two pathogenic variants in the non-mitochondrial SYNE1 gene… To our knowledge, this is the first report of a large intragenic deletion of SYNE1 in patients with cerebellar ataxia (ARCA1).” (Published 29 Nov 2023; URL: https://doi.org/10.3390/genes14122154) (serag2023acasereport pages 1-2)

2.2 Risk factors

  • Genetic: autosomal recessive inheritance; founder variants in Quebec/Eastern Quebec significantly contribute to regional burden. (dupre2007clinicalandgenetic pages 2-3, salem2021geneticandepidemiological pages 3-4)
  • Environmental: no established environmental risk factors were identified in the retrieved evidence; current understanding supports a primarily genetic etiology. (dupre2007clinicalandgenetic pages 2-3, serag2023acasereport pages 1-2)

2.3 Protective factors / gene–environment interactions

No specific protective genetic variants or gene–environment interactions were found in the retrieved evidence corpus. (dupre2007clinicalandgenetic pages 2-3, serag2023acasereport pages 1-2)


3. Phenotypes (clinical spectrum)

3.1 Core cerebellar phenotype (Quebec founder phenotype)

From the 64-subject Beauce cohort: - Age at onset: ataxia mean 31.60 years (range 17–45); dysarthria mean 34.79 years (range 17–50). (dupre2008étudecliniqueeta pages 23-29) - First symptom: ataxia 62.5%, dysarthria 12.5%, both 25%. (dupre2008étudecliniqueeta pages 23-29) - Symptom frequencies: dysarthria 100%, ataxia 98.4%, dysmetria ~90.6%; abnormal pursuit 43.8%, slow saccades 31.2%, nystagmus 9.4%; brisk lower-limb reflexes 32.8%, Babinski/clonus 6.2%. (dupre2008étudecliniqueeta pages 23-29) - Imaging: CT/MRI in 50 subjects “invariably showed marked diffuse cerebellar atrophy” with no cortical/brainstem/white-matter involvement. (dupre2008étudecliniqueeta pages 23-29) - Neurophysiology: nerve conduction studies normal in 22/22 (no peripheral neuropathy). (dupre2008étudecliniqueeta pages 23-29) - Natural history: slowly progressive to moderate disability with “no effect on life expectancy.” (dupre2007clinicalandgenetic pages 2-3, dupre2008étudecliniqueeta pages 23-29)

3.2 Broader “cerebellar-plus” phenotype (non-founder cohorts)

From the Chinese cohort (8 affected individuals): - Onset: 10–27 years (median 18). (duan2021autosomalrecessivecerebellar pages 2-4) - Phenotypic categories at last follow-up: pure cerebellar ataxia 2/8; ataxia + motor neuron disease 3/8; ataxia + cognitive impairment 2/8; ataxia + motor neuron disease + mental retardation 1/8. (duan2021autosomalrecessivecerebellar pages 2-4) - Severity metrics: SARA 12.88 ± 3.56; ICARS 33.63 ± 6.44. (duan2021autosomalrecessivecerebellar pages 2-4) - Reported extracerebellar features (compiled by authors): motor neuron disease, cognitive impairment/intellectual disability, brainstem dysfunction, musculoskeletal deformities, and others. (duan2021autosomalrecessivecerebellar pages 2-4)

Direct abstract quote (2020 accepted; published in 2021 issue): “Mutations in the synaptic nuclear envelope protein 1 (SYNE1) gene have been reported to cause autosomal recessive cerebellar ataxia (ARCA) type 1 with highly variable clinical phenotypes.” (URL: https://doi.org/10.1007/s12311-020-01186-8) (duan2021autosomalrecessivecerebellar pages 1-2)

3.3 HPO term suggestions (non-exhaustive)

Core neurologic: - Cerebellar ataxia (HP:0001251) (dupre2008étudecliniqueeta pages 23-29) - Gait ataxia (HP:0002066) (dupre2008étudecliniqueeta pages 23-29) - Limb ataxia (HP:0002060) (dupre2008étudecliniqueeta pages 23-29) - Cerebellar dysarthria / Dysarthria (HP:0001260) (dupre2008étudecliniqueeta pages 23-29) - Dysmetria (HP:0001310) (dupre2008étudecliniqueeta pages 23-29) - Abnormal smooth pursuit (HP:0000658) (dupre2008étudecliniqueeta pages 23-29) - Slow saccades (HP:0000644) (dupre2008étudecliniqueeta pages 23-29) - Nystagmus (HP:0000639) (dupre2008étudecliniqueeta pages 23-29)

Cerebellar-plus (variable): - Upper motor neuron signs / Spasticity (HP:0001257), Hyperreflexia (HP:0001347), Babinski sign (HP:0003487) (serag2023acasereport pages 1-2) - Motor neuron disease (HP:0007354) (duan2021autosomalrecessivecerebellar pages 2-4) - Cognitive impairment (HP:0100543) / Intellectual disability (HP:0001249) (duan2021autosomalrecessivecerebellar pages 2-4)

Imaging: - Cerebellar atrophy (HP:0001272) (dupre2008étudecliniqueeta pages 23-29)


4. Genetic / molecular information

4.1 Causal gene

  • SYNE1 encodes nesprin‑1, a very large nuclear envelope spectrin-repeat protein involved in LINC complexes; SYNE1 is among the largest human genes (longest isoform 147 exons; ~8797 aa protein). (duan2021autosomalrecessivecerebellar pages 1-2)

4.2 Variant classes and examples

  • Quebec founder cohort shows multiple truncating alleles, with a major recurrent allele representing ~50.8% of carrier chromosomes in the patient series. (dupre2008étudecliniqueeta pages 29-34)
  • 2023 case report identifies compound heterozygosity including a large intragenic deletion (exon 122 deletion) plus a nonsense variant c.13258C>T p.(Arg4420Ter). (serag2023acasereport pages 4-5)

4.3 Variant distribution/interpretation (expert synthesis)

  • Review of LINC-complex disease genetics notes the majority of disease-associated SYNE1 variants are coding and enriched for truncating loss-of-function, consistent with a loss-of-function mechanism, and that SCAR8 accounts for the bulk of reported SYNE1 disease associations. (kuwako2024diverserolesof pages 11-12)

4.4 Modifier genes / epigenetics / chromosomal abnormalities

No specific modifier genes or epigenetic signatures for ARCA1 were identified in the retrieved evidence corpus. (kuwako2024diverserolesof pages 11-12, serag2023acasereport pages 1-2)


5. Environmental information

No validated non-genetic environmental contributors were identified in the retrieved evidence corpus. (dupre2007clinicalandgenetic pages 2-3, serag2023acasereport pages 1-2)


6. Mechanism / pathophysiology

6.1 Current mechanistic model

  • Nesprin‑1 (SYNE1) participates in the LINC complex (SUN–KASH bridging across the nuclear envelope), physically coupling cytoskeletal forces to nuclear structure and positioning; ARCA1 is believed to arise predominantly from loss-of-function leading to absent or truncated nesprin‑1. (duan2021autosomalrecessivecerebellar pages 1-2, kuwako2024diverserolesof pages 11-12)
  • A Quebec founder analysis hypothesized impaired spectrin interactions and altered nuclear structure in cerebellar neurons (particularly Purkinje cells) as a proximate cause of cerebellar degeneration. (dupre2008étudecliniqueeta pages 34-39)

6.2 Synaptic/cerebellar isoform hypothesis (2024 review evidence)

  • A cerebellum-enriched SYNE1 isoform (KLNes1g) lacking the KASH domain localizes to mossy-fiber synapses and binds clathrin on synaptic vesicles, suggesting a synaptic mechanism contributing to cerebellar vulnerability, although direct causation remains unresolved. (kuwako2024diverserolesof pages 11-12, kuwako2024diverserolesof pages 12-14)

6.3 Model organism evidence (supporting LINC relevance to ataxia)

  • SUN1 knockout mice develop cerebellar ataxia with Purkinje cell migration/dendritic/synaptic abnormalities and mislocalization of nesprin proteins, supporting LINC-complex necessity for cerebellar motor function, even though nesprin‑1 knockout models may not fully recapitulate human SCAR8. (kuwako2024diverserolesof pages 12-14, litster2026duplicationwithin14q32.13 pages 20-23)

6.4 Suggested ontology terms

  • GO Biological Process (suggestions): nuclear migration; nuclear anchoring; cytoskeleton organization; synaptic vesicle endocytosis; mechanotransduction.
  • GO Cellular Component (suggestions): nuclear envelope; outer nuclear membrane; LINC complex; synapse.
  • CL Cell types (suggestions): Purkinje cell (cerebellar cortex), cerebellar granule neuron.

(These ontology suggestions are consistent with the described LINC/nesprin/synaptic localization evidence but were not explicitly enumerated as ontology IDs in the retrieved texts.) (kuwako2024diverserolesof pages 11-12, kuwako2024diverserolesof pages 12-14)


7. Anatomical structures affected

7.1 Primary systems/organs

  • Central nervous system, cerebellum with diffuse cerebellar atrophy is the dominant structural correlate in classic Beauce phenotype. (dupre2008étudecliniqueeta pages 23-29)

7.2 Tissue/cell populations

  • Cerebellar neuronal vulnerability is supported by the strong cerebellar expression of SYNE1 and atrophy pattern. (duan2021autosomalrecessivecerebellar pages 1-2, dupre2008étudecliniqueeta pages 23-29)

7.3 UBERON suggestions

  • Cerebellum (UBERON:0002037)
  • Cerebellar cortex (UBERON:0004720)
  • Cerebellar Purkinje cell layer (UBERON term varies by ontology release)

8. Temporal development

  • Onset: typically early-to-mid adulthood in Quebec founder cohorts (~30s), but can be childhood/young-adult in other populations. (dupre2008étudecliniqueeta pages 23-29, duan2021autosomalrecessivecerebellar pages 2-4)
  • Course: slowly progressive with moderate disability in classic Beauce phenotype; multisystem progression occurs in cerebellar-plus forms. (dupre2008étudecliniqueeta pages 23-29, duan2021autosomalrecessivecerebellar pages 2-4)

9. Inheritance and population

9.1 Inheritance

  • Autosomal recessive inheritance is consistently reported. (dupre2007clinicalandgenetic pages 2-3, serag2023acasereport pages 1-2)

9.2 Epidemiology (statistics)

Eastern Quebec regional study (published 2021; URL: https://doi.org/10.1017/cjn.2020.277): - Minimum prevalence of adult hereditary ataxias: 6.47/100,000; AR ataxias: 3.73/100,000. (salem2021geneticandepidemiological pages 1-2) - ARCA1 prevalence: 2.67/100,000. (salem2021geneticandepidemiological pages 1-2, salem2021geneticandepidemiological pages 3-4) - 52.4% of patients had a confirmed genetic diagnosis. (salem2021geneticandepidemiological pages 1-2)

Direct abstract quote (2021): “The minimum prevalence of HA in Eastern Quebec was estimated at 6.47/100 000… In total, 52.4% of patients had a confirmed genetic diagnosis. AR cerebellar ataxia type 1 (2.67/100 000)… were the most prevalent disorders identified.” (salem2021geneticandepidemiological pages 1-2)

Variant-specific minimum carrier frequencies (Eastern Quebec): examples include c.15705–12 A>G 1/134 and p.Arg2906Ter 1/200. (salem2021geneticandepidemiological pages 6-7)

Quebec prevalence estimate in Beauce-focused thesis text: ~1/1,000,000 in the Quebec population (estimate; not a modern province-wide registry-based statistic). (thiffault2009caractérisationcliniqueet pages 39-43)


10. Diagnostics

10.1 Clinical evaluation

  • Imaging: brain MRI demonstrating diffuse cerebellar atrophy is a consistent finding in classic Beauce phenotype. (dupre2008étudecliniqueeta pages 23-29)
  • Neurophysiology: normal nerve conduction studies in founder phenotype can help distinguish from ataxias with prominent neuropathy. (dupre2008étudecliniqueeta pages 23-29)
  • Quantitative ataxia scales: SARA and ICARS were used in the Chinese cohort. (duan2021autosomalrecessivecerebellar pages 2-4)

10.2 Genetic testing (current practice and recent advances)

Key recent development (2023): CNV/structural variant detection matters in SYNE1. - WES may identify one allele but miss a second pathogenic structural variant; the 2023 case required high-resolution array-CGH to detect an intragenic SYNE1 deletion. (serag2023acasereport pages 1-2, serag2023acasereport pages 4-5)

2024 diagnostic approach review (adult-onset hereditary ataxia): - Testing often requires a combination of STR expansion testing plus sequencing for conventional variants (panel/WES/WGS), and long-read sequencing is highlighted as a future unifying modality. (rudaks2024anupdateon pages 1-2)

Direct abstract quote (2024): “Testing methods include targeted evaluation of STR expansions… next generation sequencing for conventional variants… Implementing long-read sequencing has the potential to transform the diagnostic approach…” (Accepted 7 May 2024; URL: https://doi.org/10.1007/s12311-024-01703-z) (rudaks2024anupdateon pages 1-2)

Visual evidence (diagnostic algorithm): Figure 2 provides a flowchart for genetic diagnosis of adult-onset hereditary cerebellar ataxia (STR expansion testing → NGS → long-read sequencing as later option). (rudaks2024anupdateon media daaff5ba)

10.3 Differential diagnosis

  • Mitochondrial disease can be a diagnostic mimic in progressive ataxia; 2023 case report emphasizes that “more than 50% of patients with suspected mitochondrial disease could have a non-mitochondrial disorder” and shows SYNE1 can be one such cause. (serag2023acasereport pages 1-2)
  • Other hereditary ataxias (repeat-expansion SCAs, FRDA, RFC1-related disease, etc.) must be excluded depending on phenotype/inheritance per adult-onset HCA diagnostic algorithms. (rudaks2024anupdateon pages 10-12, rudaks2024anupdateon media daaff5ba)

11. Outcome / prognosis

  • In the Beauce founder phenotype, progression is slow, with evolution to moderate disability and “no effect on life expectancy.” (dupre2007clinicalandgenetic pages 2-3, dupre2008étudecliniqueeta pages 23-29)
  • Broader multisystem phenotypes may have additional morbidity (e.g., motor neuron involvement), but survival statistics were not identified in the retrieved evidence corpus. (duan2021autosomalrecessivecerebellar pages 2-4)

12. Treatment

12.1 Disease-modifying therapy

No disease-modifying or gene-targeted therapy specific to SYNE1-related ARCA1/SCAR8 was identified in the retrieved sources. (serag2023acasereport pages 1-2, rudaks2024anupdateon pages 1-2)

12.2 Supportive and rehabilitative care (current real-world implementation)

While disease-specific protocols were not provided in the retrieved papers, clinical management is typically supportive (mobility aids; PT/OT; speech therapy for dysarthria; fall prevention; management of spasticity if present) based on the dominant cerebellar syndrome and any cerebellar-plus complications. The need for structured clinical evaluation and monitoring (SARA/ICARS; cognitive testing; MRI; EMG/NCS; ECG) is explicitly described in the Chinese cohort methods. (duan2021autosomalrecessivecerebellar pages 2-4)

12.3 Clinical trials landscape (not disease-specific)

Clinical trial searches retrieved rehabilitation-focused interventional studies in neurodegenerative ataxia (e.g., cerebello-spinal tDCS; supervised rehabilitation in spastic ataxias) but none specifically targeting SYNE1/ARCA1 at the time of retrieval. Examples include NCT04153110 and NCT03120013 (tDCS in neurodegenerative ataxia) and NCT06261424 (rehabilitation program in spastic ataxias). (serag2023acasereport pages 1-2)

MAXO suggestions (supportive actions): physical therapy; occupational therapy; speech therapy; assistive device use; genetic counseling.


13. Prevention

  • Primary prevention: not applicable for established Mendelian disease except through reproductive options.
  • Genetic counseling: indicated due to autosomal recessive inheritance; carrier testing/cascade screening is relevant in families and potentially in founder populations. (dupre2007clinicalandgenetic pages 2-3, salem2021geneticandepidemiological pages 6-7)
  • Secondary prevention: early molecular diagnosis can prevent misdiagnosis and inappropriate workups (e.g., mitochondrial disease) and enables appropriate surveillance for cerebellar-plus features. (serag2023acasereport pages 1-2)

14. Other species / natural disease

No naturally occurring veterinary analogs were identified in the retrieved evidence corpus.


15. Model organisms

  • Evidence implicating LINC biology in cerebellar motor function includes SUN1 knockout mice with cerebellar ataxia phenotypes and Purkinje cell abnormalities; nesprin-1 knockout models may not fully recapitulate human SCAR8. (kuwako2024diverserolesof pages 12-14, litster2026duplicationwithin14q32.13 pages 20-23)

Notes on evidence gaps and 2023–2024 prioritization

  • Key 2023–2024 advances captured here include: (i) recognition of SYNE1 CNVs (first large intragenic deletion reported) and the need for CNV-sensitive/pangenomic diagnostics (2023), and (ii) updated adult-onset hereditary ataxia diagnostic algorithms and the expected role of long-read sequencing (2024). (serag2023acasereport pages 1-2, rudaks2024anupdateon media daaff5ba, rudaks2024anupdateon pages 1-2)
  • Disease identifiers beyond OMIM (MONDO/Orphanet/MeSH/ICD) were not present in the retrieved texts and require direct database lookup to complete a knowledge base entry. (rudaks2024anupdateon pages 7-8, szpisjak2021eyetrackingaidedcharacterizationof pages 1-2)

References

  1. (dupre2007clinicalandgenetic pages 2-3): Nicolas Dupré, François Gros‐Louis, Nicolas Chrestian, Steve Verreault, Denis Brunet, Danielle de Verteuil, Bernard Brais, Jean‐Pierre Bouchard, and Guy A. Rouleau. Clinical and genetic study of autosomal recessive cerebellar ataxia type 1. Annals of Neurology, 62:93-98, Jul 2007. URL: https://doi.org/10.1002/ana.21143, doi:10.1002/ana.21143. This article has 101 citations and is from a highest quality peer-reviewed journal.

  2. (duan2021autosomalrecessivecerebellar pages 1-2): Xiaohui Duan, Ying Hao, Zhenhua Cao, Chao Zhou, Jin Zhang, Renbin Wang, Shaojie Sun, and Weihong Gu. Autosomal recessive cerebellar ataxia type 1: phenotypic and genetic correlation in a cohort of chinese patients with syne1 variants. The Cerebellum, 20:74-82, Sep 2021. URL: https://doi.org/10.1007/s12311-020-01186-8, doi:10.1007/s12311-020-01186-8. This article has 16 citations.

  3. (kuwako2024diverserolesof pages 11-12): Ken-ichiro Kuwako and Sadafumi Suzuki. Diverse roles of the linc complex in cellular function and disease in the nervous system. International Journal of Molecular Sciences, 25:11525, Oct 2024. URL: https://doi.org/10.3390/ijms252111525, doi:10.3390/ijms252111525. This article has 4 citations.

  4. (dupre2007clinicalandgenetic pages 1-2): Nicolas Dupré, François Gros‐Louis, Nicolas Chrestian, Steve Verreault, Denis Brunet, Danielle de Verteuil, Bernard Brais, Jean‐Pierre Bouchard, and Guy A. Rouleau. Clinical and genetic study of autosomal recessive cerebellar ataxia type 1. Annals of Neurology, 62:93-98, Jul 2007. URL: https://doi.org/10.1002/ana.21143, doi:10.1002/ana.21143. This article has 101 citations and is from a highest quality peer-reviewed journal.

  5. (serag2023acasereport pages 1-2): Mounir Serag, Morgane Plutino, Perrine Charles, Jean-Philippe Azulay, Annabelle Chaussenot, Véronique Paquis-Flucklinger, Samira Ait-El-Mkadem Saadi, and Cécile Rouzier. A case report of syne1 deficiency-mimicking mitochondrial disease and the value of pangenomic investigations. Genes, 14:2154, Nov 2023. URL: https://doi.org/10.3390/genes14122154, doi:10.3390/genes14122154. This article has 1 citations.

  6. (duan2021autosomalrecessivecerebellar pages 2-4): Xiaohui Duan, Ying Hao, Zhenhua Cao, Chao Zhou, Jin Zhang, Renbin Wang, Shaojie Sun, and Weihong Gu. Autosomal recessive cerebellar ataxia type 1: phenotypic and genetic correlation in a cohort of chinese patients with syne1 variants. The Cerebellum, 20:74-82, Sep 2021. URL: https://doi.org/10.1007/s12311-020-01186-8, doi:10.1007/s12311-020-01186-8. This article has 16 citations.

  7. (rudaks2024anupdateon pages 7-8): Laura Ivete Rudaks, Dennis Yeow, Karl Ng, Ira W. Deveson, Marina L. Kennerson, and Kishore Raj Kumar. An update on the adult-onset hereditary cerebellar ataxias: novel genetic causes and new diagnostic approaches. Cerebellum (London, England), 23:2152-2168, May 2024. URL: https://doi.org/10.1007/s12311-024-01703-z, doi:10.1007/s12311-024-01703-z. This article has 54 citations.

  8. (thiffault2009caractérisationcliniqueet pages 39-43): I Thiffault. Caractérisation clinique et génétique d'une nouvelle forme d'ataxie autosomique récessive dans la population québécoise. Unknown journal, 2009.

  9. (szpisjak2021eyetrackingaidedcharacterizationof pages 1-2): Laszlo Szpisjak, Gabor Szaraz, Andras Salamon, Viola L. Nemeth, Noemi Szepfalusi, Gabor Veres, Balint Kincses, Zoltan Maroti, Tibor Kalmar, Malgorzata Rydzanicz, Rafal Ploski, Peter Klivenyi, and Denes Zadori. Eye-tracking-aided characterization of saccades and antisaccades in syne1 ataxia patients: a pilot study. BMC Neuroscience, Feb 2021. URL: https://doi.org/10.1186/s12868-021-00612-9, doi:10.1186/s12868-021-00612-9. This article has 7 citations and is from a peer-reviewed journal.

  10. (salem2021geneticandepidemiological pages 1-2): Ikhlass Haj Salem, Marie Beaudin, Monica Stumpf, Mehrdad A. Estiar, Pierre-Olivier Côté, Francis Brunet, Pierre-Luc Gamache, Guy A. Rouleau, Karim Mourabit-Amari, Ziv Gan-Or, and Nicolas Dupré. Genetic and epidemiological study of adult ataxia and spastic paraplegia in eastern quebec. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 48:655-665, Jan 2021. URL: https://doi.org/10.1017/cjn.2020.277, doi:10.1017/cjn.2020.277. This article has 12 citations.

  11. (dupre2008étudecliniqueeta pages 23-29): N Dupré. Étude clinique et génétique de l'ataxie récessive de la beauce. Unknown journal, 2008.

  12. (serag2023acasereport pages 4-5): Mounir Serag, Morgane Plutino, Perrine Charles, Jean-Philippe Azulay, Annabelle Chaussenot, Véronique Paquis-Flucklinger, Samira Ait-El-Mkadem Saadi, and Cécile Rouzier. A case report of syne1 deficiency-mimicking mitochondrial disease and the value of pangenomic investigations. Genes, 14:2154, Nov 2023. URL: https://doi.org/10.3390/genes14122154, doi:10.3390/genes14122154. This article has 1 citations.

  13. (salem2021geneticandepidemiological pages 3-4): Ikhlass Haj Salem, Marie Beaudin, Monica Stumpf, Mehrdad A. Estiar, Pierre-Olivier Côté, Francis Brunet, Pierre-Luc Gamache, Guy A. Rouleau, Karim Mourabit-Amari, Ziv Gan-Or, and Nicolas Dupré. Genetic and epidemiological study of adult ataxia and spastic paraplegia in eastern quebec. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 48:655-665, Jan 2021. URL: https://doi.org/10.1017/cjn.2020.277, doi:10.1017/cjn.2020.277. This article has 12 citations.

  14. (dupre2008étudecliniqueeta pages 29-34): N Dupré. Étude clinique et génétique de l'ataxie récessive de la beauce. Unknown journal, 2008.

  15. (dupre2008étudecliniqueeta pages 34-39): N Dupré. Étude clinique et génétique de l'ataxie récessive de la beauce. Unknown journal, 2008.

  16. (kuwako2024diverserolesof pages 12-14): Ken-ichiro Kuwako and Sadafumi Suzuki. Diverse roles of the linc complex in cellular function and disease in the nervous system. International Journal of Molecular Sciences, 25:11525, Oct 2024. URL: https://doi.org/10.3390/ijms252111525, doi:10.3390/ijms252111525. This article has 4 citations.

  17. (litster2026duplicationwithin14q32.13 pages 20-23): Thomas M Litster, Robert A Wilcox, Renée Carroll, Alison E Gardner, Nazzmer M Nazri, Cheryl A Shoubridge, Martin B Delatycki, Katja Lohmann, Marc Agzarian, Rafaela Turella Divani, Haloom Rafehi, Liam Scott, Gavin Monahan, Phillipa J Lamont, Catherine Ashton, Nigel G Laing, Gianina Ravenscroft, Melanie Bahlo, Eric Haan, Paul J Lockhart, Kathryn L Friend, Mark A Corbett, and Jozef Gecz. Duplication within 14q32.13 implicates a chimeric clmn :: syne3 rna transcript in cerebellar ataxia. Unknown journal, Apr 2026. URL: https://doi.org/10.64898/2026.04.23.26350376, doi:10.64898/2026.04.23.26350376.

  18. (salem2021geneticandepidemiological pages 6-7): Ikhlass Haj Salem, Marie Beaudin, Monica Stumpf, Mehrdad A. Estiar, Pierre-Olivier Côté, Francis Brunet, Pierre-Luc Gamache, Guy A. Rouleau, Karim Mourabit-Amari, Ziv Gan-Or, and Nicolas Dupré. Genetic and epidemiological study of adult ataxia and spastic paraplegia in eastern quebec. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 48:655-665, Jan 2021. URL: https://doi.org/10.1017/cjn.2020.277, doi:10.1017/cjn.2020.277. This article has 12 citations.

  19. (rudaks2024anupdateon pages 1-2): Laura Ivete Rudaks, Dennis Yeow, Karl Ng, Ira W. Deveson, Marina L. Kennerson, and Kishore Raj Kumar. An update on the adult-onset hereditary cerebellar ataxias: novel genetic causes and new diagnostic approaches. Cerebellum (London, England), 23:2152-2168, May 2024. URL: https://doi.org/10.1007/s12311-024-01703-z, doi:10.1007/s12311-024-01703-z. This article has 54 citations.

  20. (rudaks2024anupdateon media daaff5ba): Laura Ivete Rudaks, Dennis Yeow, Karl Ng, Ira W. Deveson, Marina L. Kennerson, and Kishore Raj Kumar. An update on the adult-onset hereditary cerebellar ataxias: novel genetic causes and new diagnostic approaches. Cerebellum (London, England), 23:2152-2168, May 2024. URL: https://doi.org/10.1007/s12311-024-01703-z, doi:10.1007/s12311-024-01703-z. This article has 54 citations.

  21. (rudaks2024anupdateon pages 10-12): Laura Ivete Rudaks, Dennis Yeow, Karl Ng, Ira W. Deveson, Marina L. Kennerson, and Kishore Raj Kumar. An update on the adult-onset hereditary cerebellar ataxias: novel genetic causes and new diagnostic approaches. Cerebellum (London, England), 23:2152-2168, May 2024. URL: https://doi.org/10.1007/s12311-024-01703-z, doi:10.1007/s12311-024-01703-z. This article has 54 citations.

Artifacts

## Context ID: pqac-00000045 Figure 2 on page 11 provides a comprehensive flowchart for the genetic diagnosis of adult-onset hereditary cerebellar ataxia. It ou